{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# TREC 2018 Precision Medicine"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "from json2html import *\n",
    "from IPython.display import HTML\n",
    "import pandas\n",
    "\n",
    "import os, sys\n",
    "nb_dir = os.path.split(os.getcwd())[0]\n",
    "if nb_dir not in sys.path:\n",
    "    sys.path.append(nb_dir)\n",
    "from trec_utils import utils, running, evaluation"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "config = utils.load_config()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>topic</th>\n",
       "      <th>disease</th>\n",
       "      <th>gene</th>\n",
       "      <th>gene1</th>\n",
       "      <th>gene2</th>\n",
       "      <th>gene3</th>\n",
       "      <th>sex</th>\n",
       "      <th>age</th>\n",
       "      <th>age_group</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>Liposarcoma</td>\n",
       "      <td>CDK4 Amplification</td>\n",
       "      <td>CDK4 Amplification</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>38</td>\n",
       "      <td>adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>Colon cancer</td>\n",
       "      <td>KRAS (G13D), BRAF (V600E)</td>\n",
       "      <td>KRAS (G13D)</td>\n",
       "      <td>BRAF (V600E)</td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>52</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>Meningioma</td>\n",
       "      <td>NF2 (K322), AKT1(E17K)</td>\n",
       "      <td>NF2 (K322)</td>\n",
       "      <td>AKT1(E17K)</td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>45</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>Breast cancer</td>\n",
       "      <td>FGFR1 Amplification, PTEN (Q171)</td>\n",
       "      <td>FGFR1 Amplification</td>\n",
       "      <td>PTEN (Q171)</td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>67</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>5</td>\n",
       "      <td>Melanoma</td>\n",
       "      <td>BRAF (V600E), CDKN2A Deletion</td>\n",
       "      <td>BRAF (V600E)</td>\n",
       "      <td>CDKN2A Deletion</td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>45</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>6</td>\n",
       "      <td>Melanoma</td>\n",
       "      <td>NRAS (Q61K)</td>\n",
       "      <td>NRAS (Q61K)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>55</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>7</td>\n",
       "      <td>Lung cancer</td>\n",
       "      <td>EGFR (L858R)</td>\n",
       "      <td>EGFR (L858R)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>50</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>8</td>\n",
       "      <td>Lung cancer</td>\n",
       "      <td>EML4-ALK Fusion transcript</td>\n",
       "      <td>EML4-ALK Fusion transcript</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>52</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>9</td>\n",
       "      <td>Gastrointestinal stromal tumor</td>\n",
       "      <td>KIT Exon 9 (A502_Y503dup)</td>\n",
       "      <td>KIT Exon 9 (A502_Y503dup)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>49</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>10</td>\n",
       "      <td>Lung adenocarcinoma</td>\n",
       "      <td>KRAS (G12C)</td>\n",
       "      <td>KRAS (G12C)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>61</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>11</td>\n",
       "      <td>Gastric cancer</td>\n",
       "      <td>PIK3CA (E545K)</td>\n",
       "      <td>PIK3CA (E545K)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>54</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>12</td>\n",
       "      <td>Colon cancer</td>\n",
       "      <td>BRAF (V600E)</td>\n",
       "      <td>BRAF (V600E)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>35</td>\n",
       "      <td>adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>13</td>\n",
       "      <td>Cholangiocarcinoma</td>\n",
       "      <td>BRCA2</td>\n",
       "      <td>BRCA2</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>72</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>14</td>\n",
       "      <td>Cholangiocarcinoma</td>\n",
       "      <td>IDH1 (R132H)</td>\n",
       "      <td>IDH1 (R132H)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>64</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>15</td>\n",
       "      <td>Cervical cancer</td>\n",
       "      <td>STK11</td>\n",
       "      <td>STK11</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>26</td>\n",
       "      <td>adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>16</td>\n",
       "      <td>Pancreatic cancer</td>\n",
       "      <td>CDKN2A</td>\n",
       "      <td>CDKN2A</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>54</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>17</td>\n",
       "      <td>Prostate cancer</td>\n",
       "      <td>PTEN Inactivating</td>\n",
       "      <td>PTEN Inactivating</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>81</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>18</td>\n",
       "      <td>Pancreatic cancer</td>\n",
       "      <td>CDK6 Amplification</td>\n",
       "      <td>CDK6 Amplification</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>48</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>19</td>\n",
       "      <td>Colorectal cancer</td>\n",
       "      <td>FGFR1 Amplification</td>\n",
       "      <td>FGFR1 Amplification</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>35</td>\n",
       "      <td>adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>20</td>\n",
       "      <td>Liposarcoma</td>\n",
       "      <td>MDM2 Amplification</td>\n",
       "      <td>MDM2 Amplification</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>26</td>\n",
       "      <td>adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>21</td>\n",
       "      <td>Lung adenocarcinoma</td>\n",
       "      <td>ALK Fusion</td>\n",
       "      <td>ALK Fusion</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>64</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>22</td>\n",
       "      <td>Lung cancer</td>\n",
       "      <td>ERBB2 Amplification</td>\n",
       "      <td>ERBB2 Amplification</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>70</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>23</td>\n",
       "      <td>Breast cancer</td>\n",
       "      <td>PTEN Loss</td>\n",
       "      <td>PTEN Loss</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>54</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>24</td>\n",
       "      <td>Lung cancer</td>\n",
       "      <td>NTRK1</td>\n",
       "      <td>NTRK1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>58</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>25</td>\n",
       "      <td>Lung adenocarcinoma</td>\n",
       "      <td>MET Amplification</td>\n",
       "      <td>MET Amplification</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>48</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>26</td>\n",
       "      <td>Breast cancer</td>\n",
       "      <td>NRAS Amplification</td>\n",
       "      <td>NRAS Amplification</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>35</td>\n",
       "      <td>adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>27</td>\n",
       "      <td>Pancreatic adenocarcinoma</td>\n",
       "      <td>KRAS, TP53</td>\n",
       "      <td>KRAS</td>\n",
       "      <td>TP53</td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>49</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>28</td>\n",
       "      <td>Pancreatic ductal adenocarcinoma</td>\n",
       "      <td>ERBB3</td>\n",
       "      <td>ERBB3</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>73</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>29</td>\n",
       "      <td>Ampullary carcinoma</td>\n",
       "      <td>KRAS</td>\n",
       "      <td>KRAS</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>61</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>30</td>\n",
       "      <td>Pancreatic adenocarcinoma</td>\n",
       "      <td>RB1, TP53, KRAS</td>\n",
       "      <td>RB1</td>\n",
       "      <td>TP53</td>\n",
       "      <td>KRAS</td>\n",
       "      <td>female</td>\n",
       "      <td>57</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    topic                           disease                              gene  \\\n",
       "1       1                       Liposarcoma                CDK4 Amplification   \n",
       "2       2                      Colon cancer         KRAS (G13D), BRAF (V600E)   \n",
       "3       3                        Meningioma            NF2 (K322), AKT1(E17K)   \n",
       "4       4                     Breast cancer  FGFR1 Amplification, PTEN (Q171)   \n",
       "5       5                          Melanoma     BRAF (V600E), CDKN2A Deletion   \n",
       "6       6                          Melanoma                       NRAS (Q61K)   \n",
       "7       7                       Lung cancer                      EGFR (L858R)   \n",
       "8       8                       Lung cancer        EML4-ALK Fusion transcript   \n",
       "9       9    Gastrointestinal stromal tumor         KIT Exon 9 (A502_Y503dup)   \n",
       "10     10               Lung adenocarcinoma                       KRAS (G12C)   \n",
       "11     11                    Gastric cancer                    PIK3CA (E545K)   \n",
       "12     12                      Colon cancer                      BRAF (V600E)   \n",
       "13     13                Cholangiocarcinoma                             BRCA2   \n",
       "14     14                Cholangiocarcinoma                      IDH1 (R132H)   \n",
       "15     15                   Cervical cancer                             STK11   \n",
       "16     16                 Pancreatic cancer                            CDKN2A   \n",
       "17     17                   Prostate cancer                 PTEN Inactivating   \n",
       "18     18                 Pancreatic cancer                CDK6 Amplification   \n",
       "19     19                 Colorectal cancer               FGFR1 Amplification   \n",
       "20     20                       Liposarcoma                MDM2 Amplification   \n",
       "21     21               Lung adenocarcinoma                        ALK Fusion   \n",
       "22     22                       Lung cancer               ERBB2 Amplification   \n",
       "23     23                     Breast cancer                         PTEN Loss   \n",
       "24     24                       Lung cancer                             NTRK1   \n",
       "25     25               Lung adenocarcinoma                 MET Amplification   \n",
       "26     26                     Breast cancer                NRAS Amplification   \n",
       "27     27         Pancreatic adenocarcinoma                        KRAS, TP53   \n",
       "28     28  Pancreatic ductal adenocarcinoma                             ERBB3   \n",
       "29     29               Ampullary carcinoma                              KRAS   \n",
       "30     30         Pancreatic adenocarcinoma                   RB1, TP53, KRAS   \n",
       "\n",
       "                         gene1             gene2  gene3     sex age age_group  \n",
       "1           CDK4 Amplification                             male  38     adult  \n",
       "2                  KRAS (G13D)      BRAF (V600E)           male  52      aged  \n",
       "3                   NF2 (K322)        AKT1(E17K)         female  45      aged  \n",
       "4          FGFR1 Amplification       PTEN (Q171)         female  67      aged  \n",
       "5                 BRAF (V600E)   CDKN2A Deletion         female  45      aged  \n",
       "6                  NRAS (Q61K)                             male  55      aged  \n",
       "7                 EGFR (L858R)                           female  50      aged  \n",
       "8   EML4-ALK Fusion transcript                             male  52      aged  \n",
       "9    KIT Exon 9 (A502_Y503dup)                           female  49      aged  \n",
       "10                 KRAS (G12C)                           female  61      aged  \n",
       "11              PIK3CA (E545K)                             male  54      aged  \n",
       "12                BRAF (V600E)                             male  35     adult  \n",
       "13                       BRCA2                             male  72      aged  \n",
       "14                IDH1 (R132H)                             male  64      aged  \n",
       "15                       STK11                           female  26     adult  \n",
       "16                      CDKN2A                             male  54      aged  \n",
       "17           PTEN Inactivating                             male  81      aged  \n",
       "18          CDK6 Amplification                             male  48      aged  \n",
       "19         FGFR1 Amplification                           female  35     adult  \n",
       "20          MDM2 Amplification                             male  26     adult  \n",
       "21                  ALK Fusion                           female  64      aged  \n",
       "22         ERBB2 Amplification                             male  70      aged  \n",
       "23                   PTEN Loss                           female  54      aged  \n",
       "24                       NTRK1                           female  58      aged  \n",
       "25           MET Amplification                             male  48      aged  \n",
       "26          NRAS Amplification                           female  35     adult  \n",
       "27                        KRAS              TP53         female  49      aged  \n",
       "28                       ERBB3                           female  73      aged  \n",
       "29                        KRAS                             male  61      aged  \n",
       "30                         RB1              TP53   KRAS  female  57      aged  "
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "topics_2017 = utils.get_topics('./topics/topics2017.xml')\n",
    "qrels_2017 = utils.get_qrels('./gold-standard/trials.2017.qrels')\n",
    "topics_2017"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>topic</th>\n",
       "      <th>disease</th>\n",
       "      <th>gene</th>\n",
       "      <th>gene1</th>\n",
       "      <th>gene2</th>\n",
       "      <th>gene3</th>\n",
       "      <th>sex</th>\n",
       "      <th>age</th>\n",
       "      <th>age_group</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>BRAF (V600E)</td>\n",
       "      <td>BRAF (V600E)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>64</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>BRAF (V600K)</td>\n",
       "      <td>BRAF (V600K)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>54</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>BRAF (V600R)</td>\n",
       "      <td>BRAF (V600R)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>80</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>BRAF (K601E)</td>\n",
       "      <td>BRAF (K601E)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>38</td>\n",
       "      <td>adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>5</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>BRAF (V600E), PTEN loss of function</td>\n",
       "      <td>BRAF (V600E)</td>\n",
       "      <td>PTEN loss of function</td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>57</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>6</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>BRAF (V600E), NRAS (Q61R)</td>\n",
       "      <td>BRAF (V600E)</td>\n",
       "      <td>NRAS (Q61R)</td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>67</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>7</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>BRAF amplification</td>\n",
       "      <td>BRAF amplification</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>61</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>8</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>NRAS (Q61R)</td>\n",
       "      <td>NRAS (Q61R)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>63</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>9</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>NRAS (Q61L)</td>\n",
       "      <td>NRAS (Q61L)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>34</td>\n",
       "      <td>adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>10</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>KIT (L576P)</td>\n",
       "      <td>KIT (L576P)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>65</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>11</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>KIT (L576P), KIT amplification</td>\n",
       "      <td>KIT (L576P)</td>\n",
       "      <td>KIT amplification</td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>56</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>12</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>KIT (K642E)</td>\n",
       "      <td>KIT (K642E)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>62</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>13</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>KIT (N822Y)</td>\n",
       "      <td>KIT (N822Y)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>39</td>\n",
       "      <td>adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>14</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>KIT amplification</td>\n",
       "      <td>KIT amplification</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>66</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>15</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>NF1 truncation</td>\n",
       "      <td>NF1 truncation</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>70</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>16</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>NTRK1 rearrangement</td>\n",
       "      <td>NTRK1 rearrangement</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>60</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>17</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>TP53 loss of function</td>\n",
       "      <td>TP53 loss of function</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>72</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>18</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>tumor cells with &gt;50% membranous PD-L1 expression</td>\n",
       "      <td>tumor cells with &gt;50% membranous PD-L1 expression</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>48</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>19</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>tumor cells negative for PD-L1 expression</td>\n",
       "      <td>tumor cells negative for PD-L1 expression</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>73</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>20</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>high tumor mutational burden</td>\n",
       "      <td>high tumor mutational burden</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>86</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>21</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>extensive tumor infiltrating lymphocytes</td>\n",
       "      <td>extensive tumor infiltrating lymphocytes</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>49</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>22</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>no tumor infiltrating lymphocytes</td>\n",
       "      <td>no tumor infiltrating lymphocytes</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>74</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>23</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>PTEN loss of function</td>\n",
       "      <td>PTEN loss of function</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>68</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>24</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>APC loss of function</td>\n",
       "      <td>APC loss of function</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>47</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>25</td>\n",
       "      <td>melanoma</td>\n",
       "      <td>high serum LDH levels</td>\n",
       "      <td>high serum LDH levels</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>69</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>26</td>\n",
       "      <td>colorectal cancer</td>\n",
       "      <td>NRAS</td>\n",
       "      <td>NRAS</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>49</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>27</td>\n",
       "      <td>medullary thyroid carcinoma</td>\n",
       "      <td>RET</td>\n",
       "      <td>RET</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>45</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>28</td>\n",
       "      <td>neuroblastoma</td>\n",
       "      <td>ALK</td>\n",
       "      <td>ALK</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>4</td>\n",
       "      <td>child</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>29</td>\n",
       "      <td>esophageal cancer</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>EGFR</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>67</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>30</td>\n",
       "      <td>lung cancer</td>\n",
       "      <td>ROS1</td>\n",
       "      <td>ROS1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>71</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>31</td>\n",
       "      <td>head and neck squamous cell carcinoma</td>\n",
       "      <td>CDKN2A</td>\n",
       "      <td>CDKN2A</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>64</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>32</td>\n",
       "      <td>leukemia</td>\n",
       "      <td>ABL1</td>\n",
       "      <td>ABL1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>4</td>\n",
       "      <td>child</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>33</td>\n",
       "      <td>gastric cancer</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>EGFR</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>60</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>34</td>\n",
       "      <td>sarcoma</td>\n",
       "      <td>MDM2</td>\n",
       "      <td>MDM2</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>78</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>35</td>\n",
       "      <td>breast cancer</td>\n",
       "      <td>CDKN2A</td>\n",
       "      <td>CDKN2A</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>73</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>36</td>\n",
       "      <td>lung cancer</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>49</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>37</td>\n",
       "      <td>non-small cell carcinoma</td>\n",
       "      <td>MET</td>\n",
       "      <td>MET</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>68</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>38</td>\n",
       "      <td>cholangiocarcinoma</td>\n",
       "      <td>IDH1</td>\n",
       "      <td>IDH1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>50</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>39</td>\n",
       "      <td>anaplastic large cell lymphoma</td>\n",
       "      <td>ALK</td>\n",
       "      <td>ALK</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>18</td>\n",
       "      <td>adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>40</td>\n",
       "      <td>breast cancer</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>56</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>41</td>\n",
       "      <td>papillary thyroid carcinoma</td>\n",
       "      <td>NTRK1</td>\n",
       "      <td>NTRK1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>46</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>42</td>\n",
       "      <td>glioblastoma</td>\n",
       "      <td>CDK6</td>\n",
       "      <td>CDK6</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>84</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>43</td>\n",
       "      <td>basal cell carcinoma</td>\n",
       "      <td>PTCH1</td>\n",
       "      <td>PTCH1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>56</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>44</td>\n",
       "      <td>glioma</td>\n",
       "      <td>BRAF</td>\n",
       "      <td>BRAF</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>82</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>45</td>\n",
       "      <td>thyroid cancer</td>\n",
       "      <td>BRAF</td>\n",
       "      <td>BRAF</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>40</td>\n",
       "      <td>adult</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>46</td>\n",
       "      <td>lung cancer</td>\n",
       "      <td>FGFR1</td>\n",
       "      <td>FGFR1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>57</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>47</td>\n",
       "      <td>prostate cancer</td>\n",
       "      <td>PTEN</td>\n",
       "      <td>PTEN</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>70</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>48</td>\n",
       "      <td>adenoid cystic carcinoma</td>\n",
       "      <td>KIT</td>\n",
       "      <td>KIT</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>female</td>\n",
       "      <td>58</td>\n",
       "      <td>aged</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>49</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>IDH1</td>\n",
       "      <td>IDH1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>1</td>\n",
       "      <td>newborn</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>50</td>\n",
       "      <td>acute myeloid leukemia</td>\n",
       "      <td>FLT3</td>\n",
       "      <td>FLT3</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>male</td>\n",
       "      <td>13</td>\n",
       "      <td>adolescent</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    topic                                disease  \\\n",
       "1       1                               melanoma   \n",
       "2       2                               melanoma   \n",
       "3       3                               melanoma   \n",
       "4       4                               melanoma   \n",
       "5       5                               melanoma   \n",
       "6       6                               melanoma   \n",
       "7       7                               melanoma   \n",
       "8       8                               melanoma   \n",
       "9       9                               melanoma   \n",
       "10     10                               melanoma   \n",
       "11     11                               melanoma   \n",
       "12     12                               melanoma   \n",
       "13     13                               melanoma   \n",
       "14     14                               melanoma   \n",
       "15     15                               melanoma   \n",
       "16     16                               melanoma   \n",
       "17     17                               melanoma   \n",
       "18     18                               melanoma   \n",
       "19     19                               melanoma   \n",
       "20     20                               melanoma   \n",
       "21     21                               melanoma   \n",
       "22     22                               melanoma   \n",
       "23     23                               melanoma   \n",
       "24     24                               melanoma   \n",
       "25     25                               melanoma   \n",
       "26     26                      colorectal cancer   \n",
       "27     27            medullary thyroid carcinoma   \n",
       "28     28                          neuroblastoma   \n",
       "29     29                      esophageal cancer   \n",
       "30     30                            lung cancer   \n",
       "31     31  head and neck squamous cell carcinoma   \n",
       "32     32                               leukemia   \n",
       "33     33                         gastric cancer   \n",
       "34     34                                sarcoma   \n",
       "35     35                          breast cancer   \n",
       "36     36                            lung cancer   \n",
       "37     37               non-small cell carcinoma   \n",
       "38     38                     cholangiocarcinoma   \n",
       "39     39         anaplastic large cell lymphoma   \n",
       "40     40                          breast cancer   \n",
       "41     41            papillary thyroid carcinoma   \n",
       "42     42                           glioblastoma   \n",
       "43     43                   basal cell carcinoma   \n",
       "44     44                                 glioma   \n",
       "45     45                         thyroid cancer   \n",
       "46     46                            lung cancer   \n",
       "47     47                        prostate cancer   \n",
       "48     48               adenoid cystic carcinoma   \n",
       "49     49                 acute myeloid leukemia   \n",
       "50     50                 acute myeloid leukemia   \n",
       "\n",
       "                                                 gene  \\\n",
       "1                                        BRAF (V600E)   \n",
       "2                                        BRAF (V600K)   \n",
       "3                                        BRAF (V600R)   \n",
       "4                                        BRAF (K601E)   \n",
       "5                 BRAF (V600E), PTEN loss of function   \n",
       "6                           BRAF (V600E), NRAS (Q61R)   \n",
       "7                                  BRAF amplification   \n",
       "8                                         NRAS (Q61R)   \n",
       "9                                         NRAS (Q61L)   \n",
       "10                                        KIT (L576P)   \n",
       "11                     KIT (L576P), KIT amplification   \n",
       "12                                        KIT (K642E)   \n",
       "13                                        KIT (N822Y)   \n",
       "14                                  KIT amplification   \n",
       "15                                     NF1 truncation   \n",
       "16                                NTRK1 rearrangement   \n",
       "17                              TP53 loss of function   \n",
       "18  tumor cells with >50% membranous PD-L1 expression   \n",
       "19          tumor cells negative for PD-L1 expression   \n",
       "20                       high tumor mutational burden   \n",
       "21           extensive tumor infiltrating lymphocytes   \n",
       "22                  no tumor infiltrating lymphocytes   \n",
       "23                              PTEN loss of function   \n",
       "24                               APC loss of function   \n",
       "25                              high serum LDH levels   \n",
       "26                                               NRAS   \n",
       "27                                                RET   \n",
       "28                                                ALK   \n",
       "29                                               EGFR   \n",
       "30                                               ROS1   \n",
       "31                                             CDKN2A   \n",
       "32                                               ABL1   \n",
       "33                                               EGFR   \n",
       "34                                               MDM2   \n",
       "35                                             CDKN2A   \n",
       "36                                              ERBB2   \n",
       "37                                                MET   \n",
       "38                                               IDH1   \n",
       "39                                                ALK   \n",
       "40                                              ERBB2   \n",
       "41                                              NTRK1   \n",
       "42                                               CDK6   \n",
       "43                                              PTCH1   \n",
       "44                                               BRAF   \n",
       "45                                               BRAF   \n",
       "46                                              FGFR1   \n",
       "47                                               PTEN   \n",
       "48                                                KIT   \n",
       "49                                               IDH1   \n",
       "50                                               FLT3   \n",
       "\n",
       "                                                gene1                   gene2  \\\n",
       "1                                        BRAF (V600E)                           \n",
       "2                                        BRAF (V600K)                           \n",
       "3                                        BRAF (V600R)                           \n",
       "4                                        BRAF (K601E)                           \n",
       "5                                        BRAF (V600E)   PTEN loss of function   \n",
       "6                                        BRAF (V600E)             NRAS (Q61R)   \n",
       "7                                  BRAF amplification                           \n",
       "8                                         NRAS (Q61R)                           \n",
       "9                                         NRAS (Q61L)                           \n",
       "10                                        KIT (L576P)                           \n",
       "11                                        KIT (L576P)       KIT amplification   \n",
       "12                                        KIT (K642E)                           \n",
       "13                                        KIT (N822Y)                           \n",
       "14                                  KIT amplification                           \n",
       "15                                     NF1 truncation                           \n",
       "16                                NTRK1 rearrangement                           \n",
       "17                              TP53 loss of function                           \n",
       "18  tumor cells with >50% membranous PD-L1 expression                           \n",
       "19          tumor cells negative for PD-L1 expression                           \n",
       "20                       high tumor mutational burden                           \n",
       "21           extensive tumor infiltrating lymphocytes                           \n",
       "22                  no tumor infiltrating lymphocytes                           \n",
       "23                              PTEN loss of function                           \n",
       "24                               APC loss of function                           \n",
       "25                              high serum LDH levels                           \n",
       "26                                               NRAS                           \n",
       "27                                                RET                           \n",
       "28                                                ALK                           \n",
       "29                                               EGFR                           \n",
       "30                                               ROS1                           \n",
       "31                                             CDKN2A                           \n",
       "32                                               ABL1                           \n",
       "33                                               EGFR                           \n",
       "34                                               MDM2                           \n",
       "35                                             CDKN2A                           \n",
       "36                                              ERBB2                           \n",
       "37                                                MET                           \n",
       "38                                               IDH1                           \n",
       "39                                                ALK                           \n",
       "40                                              ERBB2                           \n",
       "41                                              NTRK1                           \n",
       "42                                               CDK6                           \n",
       "43                                              PTCH1                           \n",
       "44                                               BRAF                           \n",
       "45                                               BRAF                           \n",
       "46                                              FGFR1                           \n",
       "47                                               PTEN                           \n",
       "48                                                KIT                           \n",
       "49                                               IDH1                           \n",
       "50                                               FLT3                           \n",
       "\n",
       "   gene3     sex age   age_group  \n",
       "1           male  64        aged  \n",
       "2           male  54        aged  \n",
       "3           male  80        aged  \n",
       "4           male  38       adult  \n",
       "5           male  57        aged  \n",
       "6           male  67        aged  \n",
       "7           male  61        aged  \n",
       "8         female  63        aged  \n",
       "9         female  34       adult  \n",
       "10        female  65        aged  \n",
       "11        female  56        aged  \n",
       "12        female  62        aged  \n",
       "13        female  39       adult  \n",
       "14        female  66        aged  \n",
       "15          male  70        aged  \n",
       "16          male  60        aged  \n",
       "17          male  72        aged  \n",
       "18        female  48        aged  \n",
       "19          male  73        aged  \n",
       "20        female  86        aged  \n",
       "21          male  49        aged  \n",
       "22        female  74        aged  \n",
       "23          male  68        aged  \n",
       "24          male  47        aged  \n",
       "25        female  69        aged  \n",
       "26          male  49        aged  \n",
       "27        female  45        aged  \n",
       "28        female   4       child  \n",
       "29          male  67        aged  \n",
       "30        female  71        aged  \n",
       "31          male  64        aged  \n",
       "32        female   4       child  \n",
       "33        female  60        aged  \n",
       "34        female  78        aged  \n",
       "35        female  73        aged  \n",
       "36        female  49        aged  \n",
       "37          male  68        aged  \n",
       "38          male  50        aged  \n",
       "39          male  18       adult  \n",
       "40        female  56        aged  \n",
       "41        female  46        aged  \n",
       "42          male  84        aged  \n",
       "43        female  56        aged  \n",
       "44          male  82        aged  \n",
       "45        female  40       adult  \n",
       "46          male  57        aged  \n",
       "47          male  70        aged  \n",
       "48        female  58        aged  \n",
       "49          male   1     newborn  \n",
       "50          male  13  adolescent  "
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "topics_2018 = utils.get_topics('./topics/topics2018.xml')\n",
    "topics_2018"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## SUBMITTED RUN 1\n",
    "\n",
    "Baseline query with bi and tri-gram search, plus grid-search optimized parameters. Evaluation: 3."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Evaluate on 2017 topics and qrels first."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RUN: imi_mug_ct1 TOPICS: 30\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "{'P_10': 0.3345, 'Rprec': 0.2428, 'ndcg': 0.3933, 'recall_1000': 0.4426}"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "run_params = {\n",
    "    'run_id':'imi_mug_ct1',\n",
    "    'query_template':'submitted/imi_mug_ct1.json'\n",
    "}\n",
    "\n",
    "run, params = running.run(topics_2017, 'TRIALS', run_params)\n",
    "results, aggregated = evaluation.evaluate(qrels_2017, run)\n",
    "\n",
    "aggregated"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Run on 2018 topics and export to file for submission"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RUN: imi_mug_ct1 TOPICS: 50\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>TOPIC_NO</th>\n",
       "      <th>Q0</th>\n",
       "      <th>ID</th>\n",
       "      <th>RANK</th>\n",
       "      <th>SCORE</th>\n",
       "      <th>RUN_NAME</th>\n",
       "      <th>TITLE</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01928940</td>\n",
       "      <td>1</td>\n",
       "      <td>69.055466</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Japan PhI\\/II of GSK2118436 and GSK1120212 Com...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01597908</td>\n",
       "      <td>2</td>\n",
       "      <td>64.085266</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Dabrafenib Plus Trametinib vs Vemurafenib Alon...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT03101254</td>\n",
       "      <td>3</td>\n",
       "      <td>62.874268</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>LY3022855 With BRAF\\/MEK Inhibition in Patient...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01897116</td>\n",
       "      <td>4</td>\n",
       "      <td>61.179360</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>A Phase I Trial of Vemurafenib and Hydroxychlo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02416232</td>\n",
       "      <td>5</td>\n",
       "      <td>61.173985</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Access Study of Trametinib for Subjects With A...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01264380</td>\n",
       "      <td>6</td>\n",
       "      <td>57.707077</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>A Study of the Effect of Food on the Pharmacok...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02427893</td>\n",
       "      <td>7</td>\n",
       "      <td>55.395550</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Trial of Vemurafenib and Cobimetinib in Patien...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01584648</td>\n",
       "      <td>8</td>\n",
       "      <td>55.200455</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>A Study Comparing Trametinib and Dabrafenib Co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01245062</td>\n",
       "      <td>9</td>\n",
       "      <td>52.056534</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>GSK1120212 vs Chemotherapy in Advanced or Meta...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01978236</td>\n",
       "      <td>10</td>\n",
       "      <td>47.847748</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Dabrafenib\\/Trametinib, BRAF or BRAF AND MEK P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01266967</td>\n",
       "      <td>11</td>\n",
       "      <td>47.765320</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>A Study of GSK2118436 in BRAF Mutant Metastati...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01682083</td>\n",
       "      <td>12</td>\n",
       "      <td>47.436123</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>A Study of the BRAF Inhibitor Dabrafenib in Co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01436656</td>\n",
       "      <td>13</td>\n",
       "      <td>44.630775</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>A Phase I Study of Oral LGX818 in Adult Patien...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01107418</td>\n",
       "      <td>14</td>\n",
       "      <td>44.543290</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>A Pharmacokinetic\\/Pharmacodynamic Study of RO...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00949702</td>\n",
       "      <td>15</td>\n",
       "      <td>43.563065</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>A Study of Vemurafenib in Previously Treated P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01164891</td>\n",
       "      <td>16</td>\n",
       "      <td>43.234093</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>A Pharmacokinetic and Metabolism Study of 14C-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01909453</td>\n",
       "      <td>17</td>\n",
       "      <td>42.899876</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Study Comparing Combination of LGX818 Plus MEK...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01006980</td>\n",
       "      <td>18</td>\n",
       "      <td>42.232056</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>A Study of Vemurafenib (RO5185426) in Comparis...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02027961</td>\n",
       "      <td>19</td>\n",
       "      <td>41.874520</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Phase 1 Safety and Tolerability of MEDI4736 in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02460068</td>\n",
       "      <td>20</td>\n",
       "      <td>39.291756</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>A Study of Fotemustine(FTM) Vs FTM and Ipilimu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02281760</td>\n",
       "      <td>21</td>\n",
       "      <td>38.434242</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Dabrafenib and Trametinib in People With BRAF ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01744171</td>\n",
       "      <td>22</td>\n",
       "      <td>37.675095</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Vaccine Therapy in Treating Patients With Adva...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01586195</td>\n",
       "      <td>23</td>\n",
       "      <td>37.346030</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Study Of Zelboraf (Vemurafenib) in Patients Wi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02447939</td>\n",
       "      <td>24</td>\n",
       "      <td>37.330444</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Pharmacokinetics of Repeat Oral Doses of Dabra...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01543698</td>\n",
       "      <td>25</td>\n",
       "      <td>36.790855</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>A Phase Ib\\/II Study of LGX818 in Combination ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02202200</td>\n",
       "      <td>26</td>\n",
       "      <td>35.723520</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Phase I-II Study With Tumor Molecular Pharmaco...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01400451</td>\n",
       "      <td>27</td>\n",
       "      <td>35.274048</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Ph I Ipilimumab Vemurafenib Combo in Patients ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02052193</td>\n",
       "      <td>28</td>\n",
       "      <td>34.502213</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Evaluation of Photosensitivity in Dabrafenib o...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01943422</td>\n",
       "      <td>29</td>\n",
       "      <td>34.327538</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Safety and Efficacy Study of Vemurafenib and H...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00405587</td>\n",
       "      <td>30</td>\n",
       "      <td>34.037174</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Safety Study of PLX4032 in Patients With Solid...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15690</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01296178</td>\n",
       "      <td>102</td>\n",
       "      <td>15.197345</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>PETHEMA-LMA10: Treatment of Acute Myeloblastic...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15691</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01719341</td>\n",
       "      <td>103</td>\n",
       "      <td>15.185656</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Study of Non-Myeloablative Haplo-identical Hae...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15692</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00597519</td>\n",
       "      <td>104</td>\n",
       "      <td>14.748605</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>A Myeloablative Conditioning Regimen and Total...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15693</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02141477</td>\n",
       "      <td>105</td>\n",
       "      <td>14.694950</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Omacetaxine and Decitabine in Acute Myelogenou...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15694</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01619761</td>\n",
       "      <td>106</td>\n",
       "      <td>14.591252</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Natural Killer (NK) Cells in Cord Blood Transp...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15695</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00887068</td>\n",
       "      <td>107</td>\n",
       "      <td>13.965541</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Controlled Study of Post-transplant Azacitidin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15696</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT03016806</td>\n",
       "      <td>108</td>\n",
       "      <td>13.896956</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Combined Cord Blood Transplant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15697</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01300611</td>\n",
       "      <td>109</td>\n",
       "      <td>13.876300</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>TXA127 in Enhancement of Engraftment in Adult ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15698</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01272245</td>\n",
       "      <td>110</td>\n",
       "      <td>13.760099</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Omacetaxine and Low Dose Cytarabine in Older P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15699</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02727803</td>\n",
       "      <td>111</td>\n",
       "      <td>13.632661</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Personalized Natural Killer (NK) Cell Therapy ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15700</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01883362</td>\n",
       "      <td>112</td>\n",
       "      <td>13.189145</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Standard of Care +\\/- Midostaurin to Prevent R...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15701</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01203722</td>\n",
       "      <td>113</td>\n",
       "      <td>13.118571</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Reduced Intensity, Partially HLA Mismatched BM...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15702</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02323113</td>\n",
       "      <td>114</td>\n",
       "      <td>12.988543</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Safety, Tolerability, and Efficacy of TAK-659 ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15703</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01995578</td>\n",
       "      <td>115</td>\n",
       "      <td>12.756809</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Maintenance Low Dose 5'-Azacitidine Post T Cel...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15704</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01342289</td>\n",
       "      <td>116</td>\n",
       "      <td>12.353203</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Shorter Course Tacrolimus After Nonmyeloablati...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15705</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01830361</td>\n",
       "      <td>117</td>\n",
       "      <td>12.322121</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Trial to Assess the Efficacy of Midostaurin (P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15706</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00412360</td>\n",
       "      <td>118</td>\n",
       "      <td>12.203186</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Single vs Double Umbilical Cord Blood Transpla...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15707</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02167958</td>\n",
       "      <td>119</td>\n",
       "      <td>10.630949</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Nonmyeloablative Hematopoietic Cell Transplant...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15708</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00972101</td>\n",
       "      <td>120</td>\n",
       "      <td>9.946753</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Infusion of Expanded Cord Blood T Cells</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15709</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01028716</td>\n",
       "      <td>121</td>\n",
       "      <td>9.696621</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Donor Peripheral Blood Stem Cell Transplant in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15710</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00498316</td>\n",
       "      <td>122</td>\n",
       "      <td>9.452005</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Cord Blood Expansion on Mesenchymal Stem Cells</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15711</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01518153</td>\n",
       "      <td>123</td>\n",
       "      <td>9.356202</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Planned Donor Lymphocyte Infusion (DLI) After ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15712</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01983761</td>\n",
       "      <td>124</td>\n",
       "      <td>8.474945</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Study of ASC-101 in Patients With Hematologic ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15713</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01875237</td>\n",
       "      <td>125</td>\n",
       "      <td>8.014325</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Donor Lymphocyte Infusion (DLI) of T-cells Gen...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15714</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00580450</td>\n",
       "      <td>126</td>\n",
       "      <td>7.926899</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Thymosin Alfa 1 in Recipients of Allogeneic He...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15715</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02747537</td>\n",
       "      <td>127</td>\n",
       "      <td>7.222199</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Treating Relapsed\\/Recurrent\\/Refractory Pedia...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15716</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00679536</td>\n",
       "      <td>128</td>\n",
       "      <td>6.463827</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Allogeneic Transplantation for Pediatric Leuke...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15717</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00411151</td>\n",
       "      <td>129</td>\n",
       "      <td>5.487846</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>Efficacy and Safety of Sunitinib in Metastatic...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15718</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02420873</td>\n",
       "      <td>130</td>\n",
       "      <td>5.471872</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>An Open-label Phase II Study of Lorvotuzumab M...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15719</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01892371</td>\n",
       "      <td>131</td>\n",
       "      <td>4.064826</td>\n",
       "      <td>imi_mug_ct1</td>\n",
       "      <td>AC220 With 5-Aza or Low Dose Cytarabine</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>15720 rows × 7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       TOPIC_NO  Q0           ID  RANK      SCORE     RUN_NAME  \\\n",
       "0             1  Q0  NCT01928940     1  69.055466  imi_mug_ct1   \n",
       "1             1  Q0  NCT01597908     2  64.085266  imi_mug_ct1   \n",
       "2             1  Q0  NCT03101254     3  62.874268  imi_mug_ct1   \n",
       "3             1  Q0  NCT01897116     4  61.179360  imi_mug_ct1   \n",
       "4             1  Q0  NCT02416232     5  61.173985  imi_mug_ct1   \n",
       "5             1  Q0  NCT01264380     6  57.707077  imi_mug_ct1   \n",
       "6             1  Q0  NCT02427893     7  55.395550  imi_mug_ct1   \n",
       "7             1  Q0  NCT01584648     8  55.200455  imi_mug_ct1   \n",
       "8             1  Q0  NCT01245062     9  52.056534  imi_mug_ct1   \n",
       "9             1  Q0  NCT01978236    10  47.847748  imi_mug_ct1   \n",
       "10            1  Q0  NCT01266967    11  47.765320  imi_mug_ct1   \n",
       "11            1  Q0  NCT01682083    12  47.436123  imi_mug_ct1   \n",
       "12            1  Q0  NCT01436656    13  44.630775  imi_mug_ct1   \n",
       "13            1  Q0  NCT01107418    14  44.543290  imi_mug_ct1   \n",
       "14            1  Q0  NCT00949702    15  43.563065  imi_mug_ct1   \n",
       "15            1  Q0  NCT01164891    16  43.234093  imi_mug_ct1   \n",
       "16            1  Q0  NCT01909453    17  42.899876  imi_mug_ct1   \n",
       "17            1  Q0  NCT01006980    18  42.232056  imi_mug_ct1   \n",
       "18            1  Q0  NCT02027961    19  41.874520  imi_mug_ct1   \n",
       "19            1  Q0  NCT02460068    20  39.291756  imi_mug_ct1   \n",
       "20            1  Q0  NCT02281760    21  38.434242  imi_mug_ct1   \n",
       "21            1  Q0  NCT01744171    22  37.675095  imi_mug_ct1   \n",
       "22            1  Q0  NCT01586195    23  37.346030  imi_mug_ct1   \n",
       "23            1  Q0  NCT02447939    24  37.330444  imi_mug_ct1   \n",
       "24            1  Q0  NCT01543698    25  36.790855  imi_mug_ct1   \n",
       "25            1  Q0  NCT02202200    26  35.723520  imi_mug_ct1   \n",
       "26            1  Q0  NCT01400451    27  35.274048  imi_mug_ct1   \n",
       "27            1  Q0  NCT02052193    28  34.502213  imi_mug_ct1   \n",
       "28            1  Q0  NCT01943422    29  34.327538  imi_mug_ct1   \n",
       "29            1  Q0  NCT00405587    30  34.037174  imi_mug_ct1   \n",
       "...         ...  ..          ...   ...        ...          ...   \n",
       "15690        50  Q0  NCT01296178   102  15.197345  imi_mug_ct1   \n",
       "15691        50  Q0  NCT01719341   103  15.185656  imi_mug_ct1   \n",
       "15692        50  Q0  NCT00597519   104  14.748605  imi_mug_ct1   \n",
       "15693        50  Q0  NCT02141477   105  14.694950  imi_mug_ct1   \n",
       "15694        50  Q0  NCT01619761   106  14.591252  imi_mug_ct1   \n",
       "15695        50  Q0  NCT00887068   107  13.965541  imi_mug_ct1   \n",
       "15696        50  Q0  NCT03016806   108  13.896956  imi_mug_ct1   \n",
       "15697        50  Q0  NCT01300611   109  13.876300  imi_mug_ct1   \n",
       "15698        50  Q0  NCT01272245   110  13.760099  imi_mug_ct1   \n",
       "15699        50  Q0  NCT02727803   111  13.632661  imi_mug_ct1   \n",
       "15700        50  Q0  NCT01883362   112  13.189145  imi_mug_ct1   \n",
       "15701        50  Q0  NCT01203722   113  13.118571  imi_mug_ct1   \n",
       "15702        50  Q0  NCT02323113   114  12.988543  imi_mug_ct1   \n",
       "15703        50  Q0  NCT01995578   115  12.756809  imi_mug_ct1   \n",
       "15704        50  Q0  NCT01342289   116  12.353203  imi_mug_ct1   \n",
       "15705        50  Q0  NCT01830361   117  12.322121  imi_mug_ct1   \n",
       "15706        50  Q0  NCT00412360   118  12.203186  imi_mug_ct1   \n",
       "15707        50  Q0  NCT02167958   119  10.630949  imi_mug_ct1   \n",
       "15708        50  Q0  NCT00972101   120   9.946753  imi_mug_ct1   \n",
       "15709        50  Q0  NCT01028716   121   9.696621  imi_mug_ct1   \n",
       "15710        50  Q0  NCT00498316   122   9.452005  imi_mug_ct1   \n",
       "15711        50  Q0  NCT01518153   123   9.356202  imi_mug_ct1   \n",
       "15712        50  Q0  NCT01983761   124   8.474945  imi_mug_ct1   \n",
       "15713        50  Q0  NCT01875237   125   8.014325  imi_mug_ct1   \n",
       "15714        50  Q0  NCT00580450   126   7.926899  imi_mug_ct1   \n",
       "15715        50  Q0  NCT02747537   127   7.222199  imi_mug_ct1   \n",
       "15716        50  Q0  NCT00679536   128   6.463827  imi_mug_ct1   \n",
       "15717        50  Q0  NCT00411151   129   5.487846  imi_mug_ct1   \n",
       "15718        50  Q0  NCT02420873   130   5.471872  imi_mug_ct1   \n",
       "15719        50  Q0  NCT01892371   131   4.064826  imi_mug_ct1   \n",
       "\n",
       "                                                   TITLE  \n",
       "0      Japan PhI\\/II of GSK2118436 and GSK1120212 Com...  \n",
       "1      Dabrafenib Plus Trametinib vs Vemurafenib Alon...  \n",
       "2      LY3022855 With BRAF\\/MEK Inhibition in Patient...  \n",
       "3      A Phase I Trial of Vemurafenib and Hydroxychlo...  \n",
       "4      Access Study of Trametinib for Subjects With A...  \n",
       "5      A Study of the Effect of Food on the Pharmacok...  \n",
       "6      Trial of Vemurafenib and Cobimetinib in Patien...  \n",
       "7      A Study Comparing Trametinib and Dabrafenib Co...  \n",
       "8      GSK1120212 vs Chemotherapy in Advanced or Meta...  \n",
       "9      Dabrafenib\\/Trametinib, BRAF or BRAF AND MEK P...  \n",
       "10     A Study of GSK2118436 in BRAF Mutant Metastati...  \n",
       "11     A Study of the BRAF Inhibitor Dabrafenib in Co...  \n",
       "12     A Phase I Study of Oral LGX818 in Adult Patien...  \n",
       "13     A Pharmacokinetic\\/Pharmacodynamic Study of RO...  \n",
       "14     A Study of Vemurafenib in Previously Treated P...  \n",
       "15     A Pharmacokinetic and Metabolism Study of 14C-...  \n",
       "16     Study Comparing Combination of LGX818 Plus MEK...  \n",
       "17     A Study of Vemurafenib (RO5185426) in Comparis...  \n",
       "18     Phase 1 Safety and Tolerability of MEDI4736 in...  \n",
       "19     A Study of Fotemustine(FTM) Vs FTM and Ipilimu...  \n",
       "20     Dabrafenib and Trametinib in People With BRAF ...  \n",
       "21     Vaccine Therapy in Treating Patients With Adva...  \n",
       "22     Study Of Zelboraf (Vemurafenib) in Patients Wi...  \n",
       "23     Pharmacokinetics of Repeat Oral Doses of Dabra...  \n",
       "24     A Phase Ib\\/II Study of LGX818 in Combination ...  \n",
       "25     Phase I-II Study With Tumor Molecular Pharmaco...  \n",
       "26     Ph I Ipilimumab Vemurafenib Combo in Patients ...  \n",
       "27     Evaluation of Photosensitivity in Dabrafenib o...  \n",
       "28     Safety and Efficacy Study of Vemurafenib and H...  \n",
       "29     Safety Study of PLX4032 in Patients With Solid...  \n",
       "...                                                  ...  \n",
       "15690  PETHEMA-LMA10: Treatment of Acute Myeloblastic...  \n",
       "15691  Study of Non-Myeloablative Haplo-identical Hae...  \n",
       "15692  A Myeloablative Conditioning Regimen and Total...  \n",
       "15693  Omacetaxine and Decitabine in Acute Myelogenou...  \n",
       "15694  Natural Killer (NK) Cells in Cord Blood Transp...  \n",
       "15695  Controlled Study of Post-transplant Azacitidin...  \n",
       "15696                     Combined Cord Blood Transplant  \n",
       "15697  TXA127 in Enhancement of Engraftment in Adult ...  \n",
       "15698  Omacetaxine and Low Dose Cytarabine in Older P...  \n",
       "15699  Personalized Natural Killer (NK) Cell Therapy ...  \n",
       "15700  Standard of Care +\\/- Midostaurin to Prevent R...  \n",
       "15701  Reduced Intensity, Partially HLA Mismatched BM...  \n",
       "15702  Safety, Tolerability, and Efficacy of TAK-659 ...  \n",
       "15703  Maintenance Low Dose 5'-Azacitidine Post T Cel...  \n",
       "15704  Shorter Course Tacrolimus After Nonmyeloablati...  \n",
       "15705  Trial to Assess the Efficacy of Midostaurin (P...  \n",
       "15706  Single vs Double Umbilical Cord Blood Transpla...  \n",
       "15707  Nonmyeloablative Hematopoietic Cell Transplant...  \n",
       "15708            Infusion of Expanded Cord Blood T Cells  \n",
       "15709  Donor Peripheral Blood Stem Cell Transplant in...  \n",
       "15710     Cord Blood Expansion on Mesenchymal Stem Cells  \n",
       "15711  Planned Donor Lymphocyte Infusion (DLI) After ...  \n",
       "15712  Study of ASC-101 in Patients With Hematologic ...  \n",
       "15713  Donor Lymphocyte Infusion (DLI) of T-cells Gen...  \n",
       "15714  Thymosin Alfa 1 in Recipients of Allogeneic He...  \n",
       "15715  Treating Relapsed\\/Recurrent\\/Refractory Pedia...  \n",
       "15716  Allogeneic Transplantation for Pediatric Leuke...  \n",
       "15717  Efficacy and Safety of Sunitinib in Metastatic...  \n",
       "15718  An Open-label Phase II Study of Lorvotuzumab M...  \n",
       "15719            AC220 With 5-Aza or Low Dose Cytarabine  \n",
       "\n",
       "[15720 rows x 7 columns]"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "run, run_params = running.run(topics_2018, 'TRIALS', run_params)\n",
    "run"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "utils.to_trec_run_file(run, run_params)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## SUBMITTED RUN 2\n",
    "\n",
    "Baseline query with bi and tri-gram search, plus grid-search optimized parameters. Disease must not match exclusion criteria. Evaluation: 5."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Evaluate on 2017 topics and qrels first."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RUN: imi_mug_ct2 TOPICS: 30\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "{'recall_1000': 0.2857, 'ndcg': 0.2916, 'Rprec': 0.2075, 'P_10': 0.3138}"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "run_params = {\n",
    "    'run_id':'imi_mug_ct2',\n",
    "    'query_template':'submitted/imi_mug_ct2.json'\n",
    "}\n",
    "\n",
    "run, params = running.run(topics_2017, 'TRIALS', run_params)\n",
    "results, aggregated = evaluation.evaluate(qrels_2017, run)\n",
    "\n",
    "aggregated"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Run on 2018 topics and export to file for submission"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RUN: imi_mug_ct2 TOPICS: 50\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>TOPIC_NO</th>\n",
       "      <th>Q0</th>\n",
       "      <th>ID</th>\n",
       "      <th>RANK</th>\n",
       "      <th>SCORE</th>\n",
       "      <th>RUN_NAME</th>\n",
       "      <th>TITLE</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01597908</td>\n",
       "      <td>1</td>\n",
       "      <td>64.085266</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Dabrafenib Plus Trametinib vs Vemurafenib Alon...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT03101254</td>\n",
       "      <td>2</td>\n",
       "      <td>62.874268</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>LY3022855 With BRAF\\/MEK Inhibition in Patient...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01897116</td>\n",
       "      <td>3</td>\n",
       "      <td>61.179360</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>A Phase I Trial of Vemurafenib and Hydroxychlo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02427893</td>\n",
       "      <td>4</td>\n",
       "      <td>55.395550</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Trial of Vemurafenib and Cobimetinib in Patien...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01245062</td>\n",
       "      <td>5</td>\n",
       "      <td>52.056534</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>GSK1120212 vs Chemotherapy in Advanced or Meta...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01978236</td>\n",
       "      <td>6</td>\n",
       "      <td>47.847748</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Dabrafenib\\/Trametinib, BRAF or BRAF AND MEK P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01436656</td>\n",
       "      <td>7</td>\n",
       "      <td>44.630775</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>A Phase I Study of Oral LGX818 in Adult Patien...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00949702</td>\n",
       "      <td>8</td>\n",
       "      <td>43.563065</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>A Study of Vemurafenib in Previously Treated P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02027961</td>\n",
       "      <td>9</td>\n",
       "      <td>41.874520</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Phase 1 Safety and Tolerability of MEDI4736 in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02281760</td>\n",
       "      <td>10</td>\n",
       "      <td>38.434242</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Dabrafenib and Trametinib in People With BRAF ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02447939</td>\n",
       "      <td>11</td>\n",
       "      <td>37.330444</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Pharmacokinetics of Repeat Oral Doses of Dabra...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01543698</td>\n",
       "      <td>12</td>\n",
       "      <td>36.790855</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>A Phase Ib\\/II Study of LGX818 in Combination ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02202200</td>\n",
       "      <td>13</td>\n",
       "      <td>35.723520</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Phase I-II Study With Tumor Molecular Pharmaco...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01400451</td>\n",
       "      <td>14</td>\n",
       "      <td>35.274048</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Ph I Ipilimumab Vemurafenib Combo in Patients ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01943422</td>\n",
       "      <td>15</td>\n",
       "      <td>34.327538</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Safety and Efficacy Study of Vemurafenib and H...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00405587</td>\n",
       "      <td>16</td>\n",
       "      <td>34.037174</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Safety Study of PLX4032 in Patients With Solid...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01248936</td>\n",
       "      <td>17</td>\n",
       "      <td>33.167890</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>A Study of RO5185426 in Patients With Metastat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02296996</td>\n",
       "      <td>18</td>\n",
       "      <td>32.914387</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Dabrafenib and Trametinib for BRAF-inhibitor P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01878396</td>\n",
       "      <td>19</td>\n",
       "      <td>32.723860</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Circulating Melanoma Cells in Metastatic Patie...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01942993</td>\n",
       "      <td>20</td>\n",
       "      <td>30.812380</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>The Effects of Treatment With Vemurafenib on t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02314143</td>\n",
       "      <td>21</td>\n",
       "      <td>30.229190</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Phase II Biomarker Study Comparing the Combina...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01037127</td>\n",
       "      <td>22</td>\n",
       "      <td>30.162945</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Study to Determine the Effectiveness of GSK112...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01543113</td>\n",
       "      <td>23</td>\n",
       "      <td>30.074303</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>cKIT, BRAF\\/NRAS Mutations in Advanced Melanom...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02631447</td>\n",
       "      <td>24</td>\n",
       "      <td>29.845325</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Sequential Combo Immuno and Target Therapy (SE...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01767454</td>\n",
       "      <td>25</td>\n",
       "      <td>29.736584</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Study of Dabrafenib +\\/- Trametinib in Combina...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02143999</td>\n",
       "      <td>26</td>\n",
       "      <td>29.443270</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>An Observational Study of BRAF Inhibitors Effe...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01754376</td>\n",
       "      <td>27</td>\n",
       "      <td>28.501722</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Combined BRAF-Targeted Therapy &amp; Immunotherapy...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02625337</td>\n",
       "      <td>28</td>\n",
       "      <td>27.954659</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Study Comparing Pembrolizumab With Dual MAPK P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02257424</td>\n",
       "      <td>29</td>\n",
       "      <td>27.949520</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>The BAMM Trial: BRAF, Autophagy and MEK Inhibi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01611675</td>\n",
       "      <td>30</td>\n",
       "      <td>27.787899</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Leflunomide+Vemurafenib in V600 Mutant Met. Me...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13224</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02661035</td>\n",
       "      <td>44</td>\n",
       "      <td>17.692825</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Allo HSCT Using RIC for Hematological Diseases</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13225</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01522469</td>\n",
       "      <td>45</td>\n",
       "      <td>17.333996</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Phase II Study of Crenolanib in Subjects With ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13226</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01050946</td>\n",
       "      <td>46</td>\n",
       "      <td>17.296005</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Hematopoietic Stem Cell Transplantation (HSCT)...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13227</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT03096782</td>\n",
       "      <td>47</td>\n",
       "      <td>16.985520</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Cord Blood (CB) Ex-vivo Mesenchymal Stem Cell ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13228</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00064584</td>\n",
       "      <td>48</td>\n",
       "      <td>16.593666</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Safety and Tolerance Study of Oral Doses of CT...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13229</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02626715</td>\n",
       "      <td>49</td>\n",
       "      <td>16.458660</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Reduced-Intensity Conditioning (RIC) and Myelo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13230</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02722668</td>\n",
       "      <td>50</td>\n",
       "      <td>16.056608</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>UCB Transplant for Hematological Diseases Usin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13231</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01202877</td>\n",
       "      <td>51</td>\n",
       "      <td>15.502879</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>PKC412 and 5-Azacytidine</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13232</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01471067</td>\n",
       "      <td>52</td>\n",
       "      <td>15.233032</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Cord Blood Fucosylation to Enhance Homing and ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13233</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01296178</td>\n",
       "      <td>53</td>\n",
       "      <td>15.197345</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>PETHEMA-LMA10: Treatment of Acute Myeloblastic...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13234</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00597519</td>\n",
       "      <td>54</td>\n",
       "      <td>14.748605</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>A Myeloablative Conditioning Regimen and Total...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13235</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01619761</td>\n",
       "      <td>55</td>\n",
       "      <td>14.591252</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Natural Killer (NK) Cells in Cord Blood Transp...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13236</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00887068</td>\n",
       "      <td>56</td>\n",
       "      <td>13.965541</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Controlled Study of Post-transplant Azacitidin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13237</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT03016806</td>\n",
       "      <td>57</td>\n",
       "      <td>13.896956</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Combined Cord Blood Transplant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13238</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01300611</td>\n",
       "      <td>58</td>\n",
       "      <td>13.876300</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>TXA127 in Enhancement of Engraftment in Adult ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13239</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02727803</td>\n",
       "      <td>59</td>\n",
       "      <td>13.632661</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Personalized Natural Killer (NK) Cell Therapy ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13240</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01995578</td>\n",
       "      <td>60</td>\n",
       "      <td>12.756809</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Maintenance Low Dose 5'-Azacitidine Post T Cel...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13241</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01830361</td>\n",
       "      <td>61</td>\n",
       "      <td>12.322121</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Trial to Assess the Efficacy of Midostaurin (P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13242</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00412360</td>\n",
       "      <td>62</td>\n",
       "      <td>12.203186</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Single vs Double Umbilical Cord Blood Transpla...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13243</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02167958</td>\n",
       "      <td>63</td>\n",
       "      <td>10.630949</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Nonmyeloablative Hematopoietic Cell Transplant...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13244</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00972101</td>\n",
       "      <td>64</td>\n",
       "      <td>9.946753</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Infusion of Expanded Cord Blood T Cells</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13245</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01028716</td>\n",
       "      <td>65</td>\n",
       "      <td>9.696621</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Donor Peripheral Blood Stem Cell Transplant in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13246</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00498316</td>\n",
       "      <td>66</td>\n",
       "      <td>9.452005</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Cord Blood Expansion on Mesenchymal Stem Cells</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13247</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01518153</td>\n",
       "      <td>67</td>\n",
       "      <td>9.356202</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Planned Donor Lymphocyte Infusion (DLI) After ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13248</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01983761</td>\n",
       "      <td>68</td>\n",
       "      <td>8.474945</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Study of ASC-101 in Patients With Hematologic ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13249</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01875237</td>\n",
       "      <td>69</td>\n",
       "      <td>8.014325</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Donor Lymphocyte Infusion (DLI) of T-cells Gen...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13250</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00580450</td>\n",
       "      <td>70</td>\n",
       "      <td>7.926899</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Thymosin Alfa 1 in Recipients of Allogeneic He...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13251</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02747537</td>\n",
       "      <td>71</td>\n",
       "      <td>7.222199</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Treating Relapsed\\/Recurrent\\/Refractory Pedia...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13252</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00679536</td>\n",
       "      <td>72</td>\n",
       "      <td>6.463827</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>Allogeneic Transplantation for Pediatric Leuke...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13253</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01892371</td>\n",
       "      <td>73</td>\n",
       "      <td>4.064826</td>\n",
       "      <td>imi_mug_ct2</td>\n",
       "      <td>AC220 With 5-Aza or Low Dose Cytarabine</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>13254 rows × 7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       TOPIC_NO  Q0           ID  RANK      SCORE     RUN_NAME  \\\n",
       "0             1  Q0  NCT01597908     1  64.085266  imi_mug_ct2   \n",
       "1             1  Q0  NCT03101254     2  62.874268  imi_mug_ct2   \n",
       "2             1  Q0  NCT01897116     3  61.179360  imi_mug_ct2   \n",
       "3             1  Q0  NCT02427893     4  55.395550  imi_mug_ct2   \n",
       "4             1  Q0  NCT01245062     5  52.056534  imi_mug_ct2   \n",
       "5             1  Q0  NCT01978236     6  47.847748  imi_mug_ct2   \n",
       "6             1  Q0  NCT01436656     7  44.630775  imi_mug_ct2   \n",
       "7             1  Q0  NCT00949702     8  43.563065  imi_mug_ct2   \n",
       "8             1  Q0  NCT02027961     9  41.874520  imi_mug_ct2   \n",
       "9             1  Q0  NCT02281760    10  38.434242  imi_mug_ct2   \n",
       "10            1  Q0  NCT02447939    11  37.330444  imi_mug_ct2   \n",
       "11            1  Q0  NCT01543698    12  36.790855  imi_mug_ct2   \n",
       "12            1  Q0  NCT02202200    13  35.723520  imi_mug_ct2   \n",
       "13            1  Q0  NCT01400451    14  35.274048  imi_mug_ct2   \n",
       "14            1  Q0  NCT01943422    15  34.327538  imi_mug_ct2   \n",
       "15            1  Q0  NCT00405587    16  34.037174  imi_mug_ct2   \n",
       "16            1  Q0  NCT01248936    17  33.167890  imi_mug_ct2   \n",
       "17            1  Q0  NCT02296996    18  32.914387  imi_mug_ct2   \n",
       "18            1  Q0  NCT01878396    19  32.723860  imi_mug_ct2   \n",
       "19            1  Q0  NCT01942993    20  30.812380  imi_mug_ct2   \n",
       "20            1  Q0  NCT02314143    21  30.229190  imi_mug_ct2   \n",
       "21            1  Q0  NCT01037127    22  30.162945  imi_mug_ct2   \n",
       "22            1  Q0  NCT01543113    23  30.074303  imi_mug_ct2   \n",
       "23            1  Q0  NCT02631447    24  29.845325  imi_mug_ct2   \n",
       "24            1  Q0  NCT01767454    25  29.736584  imi_mug_ct2   \n",
       "25            1  Q0  NCT02143999    26  29.443270  imi_mug_ct2   \n",
       "26            1  Q0  NCT01754376    27  28.501722  imi_mug_ct2   \n",
       "27            1  Q0  NCT02625337    28  27.954659  imi_mug_ct2   \n",
       "28            1  Q0  NCT02257424    29  27.949520  imi_mug_ct2   \n",
       "29            1  Q0  NCT01611675    30  27.787899  imi_mug_ct2   \n",
       "...         ...  ..          ...   ...        ...          ...   \n",
       "13224        50  Q0  NCT02661035    44  17.692825  imi_mug_ct2   \n",
       "13225        50  Q0  NCT01522469    45  17.333996  imi_mug_ct2   \n",
       "13226        50  Q0  NCT01050946    46  17.296005  imi_mug_ct2   \n",
       "13227        50  Q0  NCT03096782    47  16.985520  imi_mug_ct2   \n",
       "13228        50  Q0  NCT00064584    48  16.593666  imi_mug_ct2   \n",
       "13229        50  Q0  NCT02626715    49  16.458660  imi_mug_ct2   \n",
       "13230        50  Q0  NCT02722668    50  16.056608  imi_mug_ct2   \n",
       "13231        50  Q0  NCT01202877    51  15.502879  imi_mug_ct2   \n",
       "13232        50  Q0  NCT01471067    52  15.233032  imi_mug_ct2   \n",
       "13233        50  Q0  NCT01296178    53  15.197345  imi_mug_ct2   \n",
       "13234        50  Q0  NCT00597519    54  14.748605  imi_mug_ct2   \n",
       "13235        50  Q0  NCT01619761    55  14.591252  imi_mug_ct2   \n",
       "13236        50  Q0  NCT00887068    56  13.965541  imi_mug_ct2   \n",
       "13237        50  Q0  NCT03016806    57  13.896956  imi_mug_ct2   \n",
       "13238        50  Q0  NCT01300611    58  13.876300  imi_mug_ct2   \n",
       "13239        50  Q0  NCT02727803    59  13.632661  imi_mug_ct2   \n",
       "13240        50  Q0  NCT01995578    60  12.756809  imi_mug_ct2   \n",
       "13241        50  Q0  NCT01830361    61  12.322121  imi_mug_ct2   \n",
       "13242        50  Q0  NCT00412360    62  12.203186  imi_mug_ct2   \n",
       "13243        50  Q0  NCT02167958    63  10.630949  imi_mug_ct2   \n",
       "13244        50  Q0  NCT00972101    64   9.946753  imi_mug_ct2   \n",
       "13245        50  Q0  NCT01028716    65   9.696621  imi_mug_ct2   \n",
       "13246        50  Q0  NCT00498316    66   9.452005  imi_mug_ct2   \n",
       "13247        50  Q0  NCT01518153    67   9.356202  imi_mug_ct2   \n",
       "13248        50  Q0  NCT01983761    68   8.474945  imi_mug_ct2   \n",
       "13249        50  Q0  NCT01875237    69   8.014325  imi_mug_ct2   \n",
       "13250        50  Q0  NCT00580450    70   7.926899  imi_mug_ct2   \n",
       "13251        50  Q0  NCT02747537    71   7.222199  imi_mug_ct2   \n",
       "13252        50  Q0  NCT00679536    72   6.463827  imi_mug_ct2   \n",
       "13253        50  Q0  NCT01892371    73   4.064826  imi_mug_ct2   \n",
       "\n",
       "                                                   TITLE  \n",
       "0      Dabrafenib Plus Trametinib vs Vemurafenib Alon...  \n",
       "1      LY3022855 With BRAF\\/MEK Inhibition in Patient...  \n",
       "2      A Phase I Trial of Vemurafenib and Hydroxychlo...  \n",
       "3      Trial of Vemurafenib and Cobimetinib in Patien...  \n",
       "4      GSK1120212 vs Chemotherapy in Advanced or Meta...  \n",
       "5      Dabrafenib\\/Trametinib, BRAF or BRAF AND MEK P...  \n",
       "6      A Phase I Study of Oral LGX818 in Adult Patien...  \n",
       "7      A Study of Vemurafenib in Previously Treated P...  \n",
       "8      Phase 1 Safety and Tolerability of MEDI4736 in...  \n",
       "9      Dabrafenib and Trametinib in People With BRAF ...  \n",
       "10     Pharmacokinetics of Repeat Oral Doses of Dabra...  \n",
       "11     A Phase Ib\\/II Study of LGX818 in Combination ...  \n",
       "12     Phase I-II Study With Tumor Molecular Pharmaco...  \n",
       "13     Ph I Ipilimumab Vemurafenib Combo in Patients ...  \n",
       "14     Safety and Efficacy Study of Vemurafenib and H...  \n",
       "15     Safety Study of PLX4032 in Patients With Solid...  \n",
       "16     A Study of RO5185426 in Patients With Metastat...  \n",
       "17     Dabrafenib and Trametinib for BRAF-inhibitor P...  \n",
       "18     Circulating Melanoma Cells in Metastatic Patie...  \n",
       "19     The Effects of Treatment With Vemurafenib on t...  \n",
       "20     Phase II Biomarker Study Comparing the Combina...  \n",
       "21     Study to Determine the Effectiveness of GSK112...  \n",
       "22     cKIT, BRAF\\/NRAS Mutations in Advanced Melanom...  \n",
       "23     Sequential Combo Immuno and Target Therapy (SE...  \n",
       "24     Study of Dabrafenib +\\/- Trametinib in Combina...  \n",
       "25     An Observational Study of BRAF Inhibitors Effe...  \n",
       "26     Combined BRAF-Targeted Therapy & Immunotherapy...  \n",
       "27     Study Comparing Pembrolizumab With Dual MAPK P...  \n",
       "28     The BAMM Trial: BRAF, Autophagy and MEK Inhibi...  \n",
       "29     Leflunomide+Vemurafenib in V600 Mutant Met. Me...  \n",
       "...                                                  ...  \n",
       "13224     Allo HSCT Using RIC for Hematological Diseases  \n",
       "13225  Phase II Study of Crenolanib in Subjects With ...  \n",
       "13226  Hematopoietic Stem Cell Transplantation (HSCT)...  \n",
       "13227  Cord Blood (CB) Ex-vivo Mesenchymal Stem Cell ...  \n",
       "13228  Safety and Tolerance Study of Oral Doses of CT...  \n",
       "13229  Reduced-Intensity Conditioning (RIC) and Myelo...  \n",
       "13230  UCB Transplant for Hematological Diseases Usin...  \n",
       "13231                           PKC412 and 5-Azacytidine  \n",
       "13232  Cord Blood Fucosylation to Enhance Homing and ...  \n",
       "13233  PETHEMA-LMA10: Treatment of Acute Myeloblastic...  \n",
       "13234  A Myeloablative Conditioning Regimen and Total...  \n",
       "13235  Natural Killer (NK) Cells in Cord Blood Transp...  \n",
       "13236  Controlled Study of Post-transplant Azacitidin...  \n",
       "13237                     Combined Cord Blood Transplant  \n",
       "13238  TXA127 in Enhancement of Engraftment in Adult ...  \n",
       "13239  Personalized Natural Killer (NK) Cell Therapy ...  \n",
       "13240  Maintenance Low Dose 5'-Azacitidine Post T Cel...  \n",
       "13241  Trial to Assess the Efficacy of Midostaurin (P...  \n",
       "13242  Single vs Double Umbilical Cord Blood Transpla...  \n",
       "13243  Nonmyeloablative Hematopoietic Cell Transplant...  \n",
       "13244            Infusion of Expanded Cord Blood T Cells  \n",
       "13245  Donor Peripheral Blood Stem Cell Transplant in...  \n",
       "13246     Cord Blood Expansion on Mesenchymal Stem Cells  \n",
       "13247  Planned Donor Lymphocyte Infusion (DLI) After ...  \n",
       "13248  Study of ASC-101 in Patients With Hematologic ...  \n",
       "13249  Donor Lymphocyte Infusion (DLI) of T-cells Gen...  \n",
       "13250  Thymosin Alfa 1 in Recipients of Allogeneic He...  \n",
       "13251  Treating Relapsed\\/Recurrent\\/Refractory Pedia...  \n",
       "13252  Allogeneic Transplantation for Pediatric Leuke...  \n",
       "13253            AC220 With 5-Aza or Low Dose Cytarabine  \n",
       "\n",
       "[13254 rows x 7 columns]"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "run, run_params = running.run(topics_2018, 'TRIALS', run_params)\n",
    "run"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "utils.to_trec_run_file(run, run_params)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## SUBMITTED RUN 3\n",
    "\n",
    "Baseline query with bi and tri-gram search, plus grid-search optimized parameters. All should (relaxed). Evaluation: 4."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Evaluate on 2017 topics and qrels first."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RUN: imi_mug_ct3 TOPICS: 30\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "{'recall_1000': 0.4587, 'ndcg': 0.2837, 'Rprec': 0.0917, 'P_10': 0.18}"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "run_params = {\n",
    "    'run_id':'imi_mug_ct3',\n",
    "    'query_template':'submitted/imi_mug_ct3.json'\n",
    "}\n",
    "\n",
    "run, params = running.run(topics_2017, 'TRIALS', run_params)\n",
    "results, aggregated = evaluation.evaluate(qrels_2017, run)\n",
    "\n",
    "aggregated"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Run on 2018 topics and export to file for submission"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RUN: imi_mug_ct3 TOPICS: 50\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>TOPIC_NO</th>\n",
       "      <th>Q0</th>\n",
       "      <th>ID</th>\n",
       "      <th>RANK</th>\n",
       "      <th>SCORE</th>\n",
       "      <th>RUN_NAME</th>\n",
       "      <th>TITLE</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01928940</td>\n",
       "      <td>1</td>\n",
       "      <td>69.055466</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Japan PhI\\/II of GSK2118436 and GSK1120212 Com...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01597908</td>\n",
       "      <td>2</td>\n",
       "      <td>64.085266</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Dabrafenib Plus Trametinib vs Vemurafenib Alon...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT03101254</td>\n",
       "      <td>3</td>\n",
       "      <td>62.874268</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>LY3022855 With BRAF\\/MEK Inhibition in Patient...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01897116</td>\n",
       "      <td>4</td>\n",
       "      <td>61.179363</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>A Phase I Trial of Vemurafenib and Hydroxychlo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02416232</td>\n",
       "      <td>5</td>\n",
       "      <td>61.173985</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Access Study of Trametinib for Subjects With A...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02672358</td>\n",
       "      <td>6</td>\n",
       "      <td>59.796140</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Study of Efficacy and Safety of Dabrafenib and...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01264380</td>\n",
       "      <td>7</td>\n",
       "      <td>57.707077</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>A Study of the Effect of Food on the Pharmacok...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02034110</td>\n",
       "      <td>8</td>\n",
       "      <td>55.676216</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Efficacy and Safety of the Combination Therapy...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02427893</td>\n",
       "      <td>9</td>\n",
       "      <td>55.395550</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Trial of Vemurafenib and Cobimetinib in Patien...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01584648</td>\n",
       "      <td>10</td>\n",
       "      <td>55.200455</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>A Study Comparing Trametinib and Dabrafenib Co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01417442</td>\n",
       "      <td>11</td>\n",
       "      <td>54.359585</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>BRAF V600E Mutations In Papillary Thyroid Carc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01245062</td>\n",
       "      <td>12</td>\n",
       "      <td>52.056538</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>GSK1120212 vs Chemotherapy in Advanced or Meta...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01978236</td>\n",
       "      <td>13</td>\n",
       "      <td>47.847748</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Dabrafenib\\/Trametinib, BRAF or BRAF AND MEK P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01266967</td>\n",
       "      <td>14</td>\n",
       "      <td>47.765320</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>A Study of GSK2118436 in BRAF Mutant Metastati...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01682083</td>\n",
       "      <td>15</td>\n",
       "      <td>47.436123</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>A Study of the BRAF Inhibitor Dabrafenib in Co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01436656</td>\n",
       "      <td>16</td>\n",
       "      <td>44.630775</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>A Phase I Study of Oral LGX818 in Adult Patien...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01107418</td>\n",
       "      <td>17</td>\n",
       "      <td>44.543290</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>A Pharmacokinetic\\/Pharmacodynamic Study of RO...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00949702</td>\n",
       "      <td>18</td>\n",
       "      <td>43.563065</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>A Study of Vemurafenib in Previously Treated P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01164891</td>\n",
       "      <td>19</td>\n",
       "      <td>43.234097</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>A Pharmacokinetic and Metabolism Study of 14C-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01534897</td>\n",
       "      <td>20</td>\n",
       "      <td>42.914204</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Re-differentiation of Radioiodine-Refractory B...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01909453</td>\n",
       "      <td>21</td>\n",
       "      <td>42.899876</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Study Comparing Combination of LGX818 Plus MEK...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01006980</td>\n",
       "      <td>22</td>\n",
       "      <td>42.232056</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>A Study of Vemurafenib (RO5185426) in Comparis...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02027961</td>\n",
       "      <td>23</td>\n",
       "      <td>41.874520</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Phase 1 Safety and Tolerability of MEDI4736 in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02460068</td>\n",
       "      <td>24</td>\n",
       "      <td>39.291756</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>A Study of Fotemustine(FTM) Vs FTM and Ipilimu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02281760</td>\n",
       "      <td>25</td>\n",
       "      <td>38.434242</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Dabrafenib and Trametinib in People With BRAF ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01744171</td>\n",
       "      <td>26</td>\n",
       "      <td>37.675095</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Vaccine Therapy in Treating Patients With Adva...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01586195</td>\n",
       "      <td>27</td>\n",
       "      <td>37.346035</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Study Of Zelboraf (Vemurafenib) in Patients Wi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02447939</td>\n",
       "      <td>28</td>\n",
       "      <td>37.330444</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Pharmacokinetics of Repeat Oral Doses of Dabra...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01543698</td>\n",
       "      <td>29</td>\n",
       "      <td>36.790855</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>A Phase Ib\\/II Study of LGX818 in Combination ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02202200</td>\n",
       "      <td>30</td>\n",
       "      <td>35.723520</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Phase I-II Study With Tumor Molecular Pharmaco...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49970</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01284712</td>\n",
       "      <td>971</td>\n",
       "      <td>33.257610</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Natural Killer Cells and Polycythemia Vera (Va...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49971</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01819558</td>\n",
       "      <td>972</td>\n",
       "      <td>33.239487</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Phase I\\/II Study of Immune Therapy After Allo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49972</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02538965</td>\n",
       "      <td>973</td>\n",
       "      <td>33.238384</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>A Study of Lenalidomide in Pediatric Subjects ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49973</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02283190</td>\n",
       "      <td>974</td>\n",
       "      <td>33.238200</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>1336GCC: Study of Erwinaze for Treatment of Ac...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49974</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02774850</td>\n",
       "      <td>975</td>\n",
       "      <td>33.223454</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Home Away From Home - Medical Outcomes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49975</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02829840</td>\n",
       "      <td>976</td>\n",
       "      <td>33.130302</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Dose-Escalation Study of Ponatinib, a FLT3 Inh...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49976</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01570465</td>\n",
       "      <td>977</td>\n",
       "      <td>33.130005</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Prospective Study on Severe Infections on Acut...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49977</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT03080766</td>\n",
       "      <td>978</td>\n",
       "      <td>33.105762</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>The Use of Decitabine as Induction Therapy for...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49978</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01707004</td>\n",
       "      <td>979</td>\n",
       "      <td>33.053970</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Decitabine and Total-Body Irradiation Followed...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49979</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01464047</td>\n",
       "      <td>980</td>\n",
       "      <td>33.045740</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Korean Post-marketing Surveillance for Sprycel...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49980</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01991249</td>\n",
       "      <td>981</td>\n",
       "      <td>33.044224</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Targeted High Throughput Sequencing in the Dia...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49981</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01749293</td>\n",
       "      <td>982</td>\n",
       "      <td>33.032120</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Partially HLA Mismatched (Haploidentical) Allo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49982</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01822509</td>\n",
       "      <td>983</td>\n",
       "      <td>33.014984</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Ipilimumab or Nivolumab in Treating Patients W...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49983</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02882321</td>\n",
       "      <td>984</td>\n",
       "      <td>33.013570</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Study of IACS-010759 in Subjects With Relapsed...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49984</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02742727</td>\n",
       "      <td>985</td>\n",
       "      <td>32.986767</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>CAR-pNK Cell Immunotherapy in CD7 Positive Leu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49985</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02421926</td>\n",
       "      <td>986</td>\n",
       "      <td>32.965553</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Extension Study of IDEAL (Imatinib) for Chroni...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49986</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01034449</td>\n",
       "      <td>987</td>\n",
       "      <td>32.943176</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Transplantation of Ex-vivo Expanded Cord Blood...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49987</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02527447</td>\n",
       "      <td>988</td>\n",
       "      <td>32.916206</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Biomarkers for Personalized Early Assessment o...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49988</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01887561</td>\n",
       "      <td>989</td>\n",
       "      <td>32.893425</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Dasatinib for Patients Achieving Complete Mole...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49989</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00815321</td>\n",
       "      <td>990</td>\n",
       "      <td>32.888912</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Autologous Cytokine Induced Killer Cells (CIK)...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49990</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01220648</td>\n",
       "      <td>991</td>\n",
       "      <td>32.869884</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Determining the Maximum Tolerated Dose of Low ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49991</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01592136</td>\n",
       "      <td>992</td>\n",
       "      <td>32.856934</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Expanded Access Program of Ponatinib</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49992</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01787474</td>\n",
       "      <td>993</td>\n",
       "      <td>32.819140</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>IL-21-Expanded NK Cells for Induction of Acute...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49993</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00905034</td>\n",
       "      <td>994</td>\n",
       "      <td>32.818752</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Methotrexate, Vincristine, Pegylated L-Asparag...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49994</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02785900</td>\n",
       "      <td>995</td>\n",
       "      <td>32.768860</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Vadastuximab Talirine (SGN-CD33A; 33A) Combine...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49995</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01068301</td>\n",
       "      <td>996</td>\n",
       "      <td>32.760937</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>A Pediatric Study of a Plerixafor Containing R...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49996</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02709083</td>\n",
       "      <td>997</td>\n",
       "      <td>32.742188</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Dasatinib or Nilotinib Followed by Imatinib in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49997</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00003875</td>\n",
       "      <td>998</td>\n",
       "      <td>32.728985</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Busulfan and Etoposide Followed by Peripheral ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49998</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00454480</td>\n",
       "      <td>999</td>\n",
       "      <td>32.728985</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Combination Chemotherapy With or Without Gemtu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49999</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02734823</td>\n",
       "      <td>1000</td>\n",
       "      <td>32.726448</td>\n",
       "      <td>imi_mug_ct3</td>\n",
       "      <td>Long Term Effects of Tyrosine Kinase Inhibitor...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>50000 rows × 7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       TOPIC_NO  Q0           ID  RANK      SCORE     RUN_NAME  \\\n",
       "0             1  Q0  NCT01928940     1  69.055466  imi_mug_ct3   \n",
       "1             1  Q0  NCT01597908     2  64.085266  imi_mug_ct3   \n",
       "2             1  Q0  NCT03101254     3  62.874268  imi_mug_ct3   \n",
       "3             1  Q0  NCT01897116     4  61.179363  imi_mug_ct3   \n",
       "4             1  Q0  NCT02416232     5  61.173985  imi_mug_ct3   \n",
       "5             1  Q0  NCT02672358     6  59.796140  imi_mug_ct3   \n",
       "6             1  Q0  NCT01264380     7  57.707077  imi_mug_ct3   \n",
       "7             1  Q0  NCT02034110     8  55.676216  imi_mug_ct3   \n",
       "8             1  Q0  NCT02427893     9  55.395550  imi_mug_ct3   \n",
       "9             1  Q0  NCT01584648    10  55.200455  imi_mug_ct3   \n",
       "10            1  Q0  NCT01417442    11  54.359585  imi_mug_ct3   \n",
       "11            1  Q0  NCT01245062    12  52.056538  imi_mug_ct3   \n",
       "12            1  Q0  NCT01978236    13  47.847748  imi_mug_ct3   \n",
       "13            1  Q0  NCT01266967    14  47.765320  imi_mug_ct3   \n",
       "14            1  Q0  NCT01682083    15  47.436123  imi_mug_ct3   \n",
       "15            1  Q0  NCT01436656    16  44.630775  imi_mug_ct3   \n",
       "16            1  Q0  NCT01107418    17  44.543290  imi_mug_ct3   \n",
       "17            1  Q0  NCT00949702    18  43.563065  imi_mug_ct3   \n",
       "18            1  Q0  NCT01164891    19  43.234097  imi_mug_ct3   \n",
       "19            1  Q0  NCT01534897    20  42.914204  imi_mug_ct3   \n",
       "20            1  Q0  NCT01909453    21  42.899876  imi_mug_ct3   \n",
       "21            1  Q0  NCT01006980    22  42.232056  imi_mug_ct3   \n",
       "22            1  Q0  NCT02027961    23  41.874520  imi_mug_ct3   \n",
       "23            1  Q0  NCT02460068    24  39.291756  imi_mug_ct3   \n",
       "24            1  Q0  NCT02281760    25  38.434242  imi_mug_ct3   \n",
       "25            1  Q0  NCT01744171    26  37.675095  imi_mug_ct3   \n",
       "26            1  Q0  NCT01586195    27  37.346035  imi_mug_ct3   \n",
       "27            1  Q0  NCT02447939    28  37.330444  imi_mug_ct3   \n",
       "28            1  Q0  NCT01543698    29  36.790855  imi_mug_ct3   \n",
       "29            1  Q0  NCT02202200    30  35.723520  imi_mug_ct3   \n",
       "...         ...  ..          ...   ...        ...          ...   \n",
       "49970        50  Q0  NCT01284712   971  33.257610  imi_mug_ct3   \n",
       "49971        50  Q0  NCT01819558   972  33.239487  imi_mug_ct3   \n",
       "49972        50  Q0  NCT02538965   973  33.238384  imi_mug_ct3   \n",
       "49973        50  Q0  NCT02283190   974  33.238200  imi_mug_ct3   \n",
       "49974        50  Q0  NCT02774850   975  33.223454  imi_mug_ct3   \n",
       "49975        50  Q0  NCT02829840   976  33.130302  imi_mug_ct3   \n",
       "49976        50  Q0  NCT01570465   977  33.130005  imi_mug_ct3   \n",
       "49977        50  Q0  NCT03080766   978  33.105762  imi_mug_ct3   \n",
       "49978        50  Q0  NCT01707004   979  33.053970  imi_mug_ct3   \n",
       "49979        50  Q0  NCT01464047   980  33.045740  imi_mug_ct3   \n",
       "49980        50  Q0  NCT01991249   981  33.044224  imi_mug_ct3   \n",
       "49981        50  Q0  NCT01749293   982  33.032120  imi_mug_ct3   \n",
       "49982        50  Q0  NCT01822509   983  33.014984  imi_mug_ct3   \n",
       "49983        50  Q0  NCT02882321   984  33.013570  imi_mug_ct3   \n",
       "49984        50  Q0  NCT02742727   985  32.986767  imi_mug_ct3   \n",
       "49985        50  Q0  NCT02421926   986  32.965553  imi_mug_ct3   \n",
       "49986        50  Q0  NCT01034449   987  32.943176  imi_mug_ct3   \n",
       "49987        50  Q0  NCT02527447   988  32.916206  imi_mug_ct3   \n",
       "49988        50  Q0  NCT01887561   989  32.893425  imi_mug_ct3   \n",
       "49989        50  Q0  NCT00815321   990  32.888912  imi_mug_ct3   \n",
       "49990        50  Q0  NCT01220648   991  32.869884  imi_mug_ct3   \n",
       "49991        50  Q0  NCT01592136   992  32.856934  imi_mug_ct3   \n",
       "49992        50  Q0  NCT01787474   993  32.819140  imi_mug_ct3   \n",
       "49993        50  Q0  NCT00905034   994  32.818752  imi_mug_ct3   \n",
       "49994        50  Q0  NCT02785900   995  32.768860  imi_mug_ct3   \n",
       "49995        50  Q0  NCT01068301   996  32.760937  imi_mug_ct3   \n",
       "49996        50  Q0  NCT02709083   997  32.742188  imi_mug_ct3   \n",
       "49997        50  Q0  NCT00003875   998  32.728985  imi_mug_ct3   \n",
       "49998        50  Q0  NCT00454480   999  32.728985  imi_mug_ct3   \n",
       "49999        50  Q0  NCT02734823  1000  32.726448  imi_mug_ct3   \n",
       "\n",
       "                                                   TITLE  \n",
       "0      Japan PhI\\/II of GSK2118436 and GSK1120212 Com...  \n",
       "1      Dabrafenib Plus Trametinib vs Vemurafenib Alon...  \n",
       "2      LY3022855 With BRAF\\/MEK Inhibition in Patient...  \n",
       "3      A Phase I Trial of Vemurafenib and Hydroxychlo...  \n",
       "4      Access Study of Trametinib for Subjects With A...  \n",
       "5      Study of Efficacy and Safety of Dabrafenib and...  \n",
       "6      A Study of the Effect of Food on the Pharmacok...  \n",
       "7      Efficacy and Safety of the Combination Therapy...  \n",
       "8      Trial of Vemurafenib and Cobimetinib in Patien...  \n",
       "9      A Study Comparing Trametinib and Dabrafenib Co...  \n",
       "10     BRAF V600E Mutations In Papillary Thyroid Carc...  \n",
       "11     GSK1120212 vs Chemotherapy in Advanced or Meta...  \n",
       "12     Dabrafenib\\/Trametinib, BRAF or BRAF AND MEK P...  \n",
       "13     A Study of GSK2118436 in BRAF Mutant Metastati...  \n",
       "14     A Study of the BRAF Inhibitor Dabrafenib in Co...  \n",
       "15     A Phase I Study of Oral LGX818 in Adult Patien...  \n",
       "16     A Pharmacokinetic\\/Pharmacodynamic Study of RO...  \n",
       "17     A Study of Vemurafenib in Previously Treated P...  \n",
       "18     A Pharmacokinetic and Metabolism Study of 14C-...  \n",
       "19     Re-differentiation of Radioiodine-Refractory B...  \n",
       "20     Study Comparing Combination of LGX818 Plus MEK...  \n",
       "21     A Study of Vemurafenib (RO5185426) in Comparis...  \n",
       "22     Phase 1 Safety and Tolerability of MEDI4736 in...  \n",
       "23     A Study of Fotemustine(FTM) Vs FTM and Ipilimu...  \n",
       "24     Dabrafenib and Trametinib in People With BRAF ...  \n",
       "25     Vaccine Therapy in Treating Patients With Adva...  \n",
       "26     Study Of Zelboraf (Vemurafenib) in Patients Wi...  \n",
       "27     Pharmacokinetics of Repeat Oral Doses of Dabra...  \n",
       "28     A Phase Ib\\/II Study of LGX818 in Combination ...  \n",
       "29     Phase I-II Study With Tumor Molecular Pharmaco...  \n",
       "...                                                  ...  \n",
       "49970  Natural Killer Cells and Polycythemia Vera (Va...  \n",
       "49971  Phase I\\/II Study of Immune Therapy After Allo...  \n",
       "49972  A Study of Lenalidomide in Pediatric Subjects ...  \n",
       "49973  1336GCC: Study of Erwinaze for Treatment of Ac...  \n",
       "49974             Home Away From Home - Medical Outcomes  \n",
       "49975  Dose-Escalation Study of Ponatinib, a FLT3 Inh...  \n",
       "49976  Prospective Study on Severe Infections on Acut...  \n",
       "49977  The Use of Decitabine as Induction Therapy for...  \n",
       "49978  Decitabine and Total-Body Irradiation Followed...  \n",
       "49979  Korean Post-marketing Surveillance for Sprycel...  \n",
       "49980  Targeted High Throughput Sequencing in the Dia...  \n",
       "49981  Partially HLA Mismatched (Haploidentical) Allo...  \n",
       "49982  Ipilimumab or Nivolumab in Treating Patients W...  \n",
       "49983  Study of IACS-010759 in Subjects With Relapsed...  \n",
       "49984  CAR-pNK Cell Immunotherapy in CD7 Positive Leu...  \n",
       "49985  Extension Study of IDEAL (Imatinib) for Chroni...  \n",
       "49986  Transplantation of Ex-vivo Expanded Cord Blood...  \n",
       "49987  Biomarkers for Personalized Early Assessment o...  \n",
       "49988  Dasatinib for Patients Achieving Complete Mole...  \n",
       "49989  Autologous Cytokine Induced Killer Cells (CIK)...  \n",
       "49990  Determining the Maximum Tolerated Dose of Low ...  \n",
       "49991               Expanded Access Program of Ponatinib  \n",
       "49992  IL-21-Expanded NK Cells for Induction of Acute...  \n",
       "49993  Methotrexate, Vincristine, Pegylated L-Asparag...  \n",
       "49994  Vadastuximab Talirine (SGN-CD33A; 33A) Combine...  \n",
       "49995  A Pediatric Study of a Plerixafor Containing R...  \n",
       "49996  Dasatinib or Nilotinib Followed by Imatinib in...  \n",
       "49997  Busulfan and Etoposide Followed by Peripheral ...  \n",
       "49998  Combination Chemotherapy With or Without Gemtu...  \n",
       "49999  Long Term Effects of Tyrosine Kinase Inhibitor...  \n",
       "\n",
       "[50000 rows x 7 columns]"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "run, run_params = running.run(topics_2018, 'TRIALS', run_params)\n",
    "run"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "utils.to_trec_run_file(run, run_params)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## SUBMITTED RUN 4\n",
    "\n",
    "Baseline query with bi and tri-gram search, weighed, plus grid-search optimized parameters. Evaluation: 2."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Evaluate on 2017 topics and qrels first."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RUN: imi_mug_ct4 TOPICS: 30\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "{'recall_1000': 0.4426, 'ndcg': 0.3759, 'Rprec': 0.2333, 'P_10': 0.3207}"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "run_params = {\n",
    "    'run_id':'imi_mug_ct4',\n",
    "    'query_template':'submitted/imi_mug_ct4.json'\n",
    "}\n",
    "\n",
    "run, params = running.run(topics_2017, 'TRIALS', run_params)\n",
    "results, aggregated = evaluation.evaluate(qrels_2017, run)\n",
    "\n",
    "aggregated"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Run on 2018 topics and export to file for submission"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RUN: imi_mug_ct4 TOPICS: 50\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>TOPIC_NO</th>\n",
       "      <th>Q0</th>\n",
       "      <th>ID</th>\n",
       "      <th>RANK</th>\n",
       "      <th>SCORE</th>\n",
       "      <th>RUN_NAME</th>\n",
       "      <th>TITLE</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01597908</td>\n",
       "      <td>1</td>\n",
       "      <td>99.776420</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Dabrafenib Plus Trametinib vs Vemurafenib Alon...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01264380</td>\n",
       "      <td>2</td>\n",
       "      <td>88.740005</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>A Study of the Effect of Food on the Pharmacok...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01584648</td>\n",
       "      <td>3</td>\n",
       "      <td>86.328260</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>A Study Comparing Trametinib and Dabrafenib Co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01107418</td>\n",
       "      <td>4</td>\n",
       "      <td>81.928406</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>A Pharmacokinetic\\/Pharmacodynamic Study of RO...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01164891</td>\n",
       "      <td>5</td>\n",
       "      <td>78.969470</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>A Pharmacokinetic and Metabolism Study of 14C-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01436656</td>\n",
       "      <td>6</td>\n",
       "      <td>78.670650</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>A Phase I Study of Oral LGX818 in Adult Patien...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00949702</td>\n",
       "      <td>7</td>\n",
       "      <td>78.498184</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>A Study of Vemurafenib in Previously Treated P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01006980</td>\n",
       "      <td>8</td>\n",
       "      <td>77.923220</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>A Study of Vemurafenib (RO5185426) in Comparis...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01928940</td>\n",
       "      <td>9</td>\n",
       "      <td>77.631900</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Japan PhI\\/II of GSK2118436 and GSK1120212 Com...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01909453</td>\n",
       "      <td>10</td>\n",
       "      <td>75.470700</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Study Comparing Combination of LGX818 Plus MEK...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02027961</td>\n",
       "      <td>11</td>\n",
       "      <td>74.997505</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Phase 1 Safety and Tolerability of MEDI4736 in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01245062</td>\n",
       "      <td>12</td>\n",
       "      <td>74.750680</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>GSK1120212 vs Chemotherapy in Advanced or Meta...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT03101254</td>\n",
       "      <td>13</td>\n",
       "      <td>70.558490</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>LY3022855 With BRAF\\/MEK Inhibition in Patient...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02416232</td>\n",
       "      <td>14</td>\n",
       "      <td>68.569290</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Access Study of Trametinib for Subjects With A...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01543698</td>\n",
       "      <td>15</td>\n",
       "      <td>68.325516</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>A Phase Ib\\/II Study of LGX818 in Combination ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02460068</td>\n",
       "      <td>16</td>\n",
       "      <td>67.702560</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>A Study of Fotemustine(FTM) Vs FTM and Ipilimu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01897116</td>\n",
       "      <td>17</td>\n",
       "      <td>66.771620</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>A Phase I Trial of Vemurafenib and Hydroxychlo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01744171</td>\n",
       "      <td>18</td>\n",
       "      <td>63.607323</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Vaccine Therapy in Treating Patients With Adva...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02202200</td>\n",
       "      <td>19</td>\n",
       "      <td>62.064568</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Phase I-II Study With Tumor Molecular Pharmaco...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02447939</td>\n",
       "      <td>20</td>\n",
       "      <td>60.881496</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Pharmacokinetics of Repeat Oral Doses of Dabra...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02427893</td>\n",
       "      <td>21</td>\n",
       "      <td>58.944214</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Trial of Vemurafenib and Cobimetinib in Patien...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01978236</td>\n",
       "      <td>22</td>\n",
       "      <td>58.215893</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Dabrafenib\\/Trametinib, BRAF or BRAF AND MEK P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01682083</td>\n",
       "      <td>23</td>\n",
       "      <td>57.454370</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>A Study of the BRAF Inhibitor Dabrafenib in Co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00405587</td>\n",
       "      <td>24</td>\n",
       "      <td>57.328480</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Safety Study of PLX4032 in Patients With Solid...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01248936</td>\n",
       "      <td>25</td>\n",
       "      <td>54.632233</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>A Study of RO5185426 in Patients With Metastat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01390818</td>\n",
       "      <td>26</td>\n",
       "      <td>52.886147</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Trial of MEK Inhibitor and PI3K\\/mTOR Inhibito...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01266967</td>\n",
       "      <td>27</td>\n",
       "      <td>52.276268</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>A Study of GSK2118436 in BRAF Mutant Metastati...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01781026</td>\n",
       "      <td>28</td>\n",
       "      <td>51.930840</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Phase 2 Study of Neoadjuvant Vemurafenib in Me...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02392871</td>\n",
       "      <td>29</td>\n",
       "      <td>50.091620</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Radiotherapy &amp; Combi in Metastatic Melanoma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02314143</td>\n",
       "      <td>30</td>\n",
       "      <td>49.997604</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Phase II Biomarker Study Comparing the Combina...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15690</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02727803</td>\n",
       "      <td>102</td>\n",
       "      <td>24.880013</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Personalized Natural Killer (NK) Cell Therapy ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15691</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02418000</td>\n",
       "      <td>103</td>\n",
       "      <td>24.871485</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>A Study of E6201 for the Treatment of Advanced...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15692</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01619761</td>\n",
       "      <td>104</td>\n",
       "      <td>24.510345</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Natural Killer (NK) Cells in Cord Blood Transp...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15693</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01203722</td>\n",
       "      <td>105</td>\n",
       "      <td>22.715448</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Reduced Intensity, Partially HLA Mismatched BM...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15694</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01342289</td>\n",
       "      <td>106</td>\n",
       "      <td>22.617893</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Shorter Course Tacrolimus After Nonmyeloablati...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15695</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01995578</td>\n",
       "      <td>107</td>\n",
       "      <td>20.985016</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Maintenance Low Dose 5'-Azacitidine Post T Cel...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15696</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00412360</td>\n",
       "      <td>108</td>\n",
       "      <td>20.485146</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Single vs Double Umbilical Cord Blood Transpla...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15697</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01883362</td>\n",
       "      <td>109</td>\n",
       "      <td>20.179659</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Standard of Care +\\/- Midostaurin to Prevent R...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15698</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02167958</td>\n",
       "      <td>110</td>\n",
       "      <td>20.173386</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Nonmyeloablative Hematopoietic Cell Transplant...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15699</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00064584</td>\n",
       "      <td>111</td>\n",
       "      <td>20.051067</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Safety and Tolerance Study of Oral Doses of CT...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15700</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02440568</td>\n",
       "      <td>112</td>\n",
       "      <td>19.858310</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>AML-02: Omacetaxine With Standard-of-Care Indu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15701</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01202877</td>\n",
       "      <td>113</td>\n",
       "      <td>19.011343</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>PKC412 and 5-Azacytidine</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15702</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02141477</td>\n",
       "      <td>114</td>\n",
       "      <td>18.775341</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Omacetaxine and Decitabine in Acute Myelogenou...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15703</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00887068</td>\n",
       "      <td>115</td>\n",
       "      <td>18.490473</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Controlled Study of Post-transplant Azacitidin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15704</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01830361</td>\n",
       "      <td>116</td>\n",
       "      <td>18.398415</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Trial to Assess the Efficacy of Midostaurin (P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15705</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01272245</td>\n",
       "      <td>117</td>\n",
       "      <td>18.079590</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Omacetaxine and Low Dose Cytarabine in Older P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15706</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02323113</td>\n",
       "      <td>118</td>\n",
       "      <td>17.856297</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Safety, Tolerability, and Efficacy of TAK-659 ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15707</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00972101</td>\n",
       "      <td>119</td>\n",
       "      <td>17.804995</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Infusion of Expanded Cord Blood T Cells</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15708</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01028716</td>\n",
       "      <td>120</td>\n",
       "      <td>17.304775</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Donor Peripheral Blood Stem Cell Transplant in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15709</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01296178</td>\n",
       "      <td>121</td>\n",
       "      <td>16.886444</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>PETHEMA-LMA10: Treatment of Acute Myeloblastic...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15710</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00498316</td>\n",
       "      <td>122</td>\n",
       "      <td>16.815830</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Cord Blood Expansion on Mesenchymal Stem Cells</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15711</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01518153</td>\n",
       "      <td>123</td>\n",
       "      <td>16.327097</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Planned Donor Lymphocyte Infusion (DLI) After ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15712</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00580450</td>\n",
       "      <td>124</td>\n",
       "      <td>14.763527</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Thymosin Alfa 1 in Recipients of Allogeneic He...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15713</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01983761</td>\n",
       "      <td>125</td>\n",
       "      <td>13.991444</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Study of ASC-101 in Patients With Hematologic ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15714</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01875237</td>\n",
       "      <td>126</td>\n",
       "      <td>13.624058</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Donor Lymphocyte Infusion (DLI) of T-cells Gen...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15715</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00679536</td>\n",
       "      <td>127</td>\n",
       "      <td>10.838383</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Allogeneic Transplantation for Pediatric Leuke...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15716</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02420873</td>\n",
       "      <td>128</td>\n",
       "      <td>9.855232</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>An Open-label Phase II Study of Lorvotuzumab M...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15717</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02747537</td>\n",
       "      <td>129</td>\n",
       "      <td>8.351846</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Treating Relapsed\\/Recurrent\\/Refractory Pedia...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15718</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01892371</td>\n",
       "      <td>130</td>\n",
       "      <td>7.041186</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>AC220 With 5-Aza or Low Dose Cytarabine</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15719</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00411151</td>\n",
       "      <td>131</td>\n",
       "      <td>6.901406</td>\n",
       "      <td>imi_mug_ct4</td>\n",
       "      <td>Efficacy and Safety of Sunitinib in Metastatic...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>15720 rows × 7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       TOPIC_NO  Q0           ID  RANK      SCORE     RUN_NAME  \\\n",
       "0             1  Q0  NCT01597908     1  99.776420  imi_mug_ct4   \n",
       "1             1  Q0  NCT01264380     2  88.740005  imi_mug_ct4   \n",
       "2             1  Q0  NCT01584648     3  86.328260  imi_mug_ct4   \n",
       "3             1  Q0  NCT01107418     4  81.928406  imi_mug_ct4   \n",
       "4             1  Q0  NCT01164891     5  78.969470  imi_mug_ct4   \n",
       "5             1  Q0  NCT01436656     6  78.670650  imi_mug_ct4   \n",
       "6             1  Q0  NCT00949702     7  78.498184  imi_mug_ct4   \n",
       "7             1  Q0  NCT01006980     8  77.923220  imi_mug_ct4   \n",
       "8             1  Q0  NCT01928940     9  77.631900  imi_mug_ct4   \n",
       "9             1  Q0  NCT01909453    10  75.470700  imi_mug_ct4   \n",
       "10            1  Q0  NCT02027961    11  74.997505  imi_mug_ct4   \n",
       "11            1  Q0  NCT01245062    12  74.750680  imi_mug_ct4   \n",
       "12            1  Q0  NCT03101254    13  70.558490  imi_mug_ct4   \n",
       "13            1  Q0  NCT02416232    14  68.569290  imi_mug_ct4   \n",
       "14            1  Q0  NCT01543698    15  68.325516  imi_mug_ct4   \n",
       "15            1  Q0  NCT02460068    16  67.702560  imi_mug_ct4   \n",
       "16            1  Q0  NCT01897116    17  66.771620  imi_mug_ct4   \n",
       "17            1  Q0  NCT01744171    18  63.607323  imi_mug_ct4   \n",
       "18            1  Q0  NCT02202200    19  62.064568  imi_mug_ct4   \n",
       "19            1  Q0  NCT02447939    20  60.881496  imi_mug_ct4   \n",
       "20            1  Q0  NCT02427893    21  58.944214  imi_mug_ct4   \n",
       "21            1  Q0  NCT01978236    22  58.215893  imi_mug_ct4   \n",
       "22            1  Q0  NCT01682083    23  57.454370  imi_mug_ct4   \n",
       "23            1  Q0  NCT00405587    24  57.328480  imi_mug_ct4   \n",
       "24            1  Q0  NCT01248936    25  54.632233  imi_mug_ct4   \n",
       "25            1  Q0  NCT01390818    26  52.886147  imi_mug_ct4   \n",
       "26            1  Q0  NCT01266967    27  52.276268  imi_mug_ct4   \n",
       "27            1  Q0  NCT01781026    28  51.930840  imi_mug_ct4   \n",
       "28            1  Q0  NCT02392871    29  50.091620  imi_mug_ct4   \n",
       "29            1  Q0  NCT02314143    30  49.997604  imi_mug_ct4   \n",
       "...         ...  ..          ...   ...        ...          ...   \n",
       "15690        50  Q0  NCT02727803   102  24.880013  imi_mug_ct4   \n",
       "15691        50  Q0  NCT02418000   103  24.871485  imi_mug_ct4   \n",
       "15692        50  Q0  NCT01619761   104  24.510345  imi_mug_ct4   \n",
       "15693        50  Q0  NCT01203722   105  22.715448  imi_mug_ct4   \n",
       "15694        50  Q0  NCT01342289   106  22.617893  imi_mug_ct4   \n",
       "15695        50  Q0  NCT01995578   107  20.985016  imi_mug_ct4   \n",
       "15696        50  Q0  NCT00412360   108  20.485146  imi_mug_ct4   \n",
       "15697        50  Q0  NCT01883362   109  20.179659  imi_mug_ct4   \n",
       "15698        50  Q0  NCT02167958   110  20.173386  imi_mug_ct4   \n",
       "15699        50  Q0  NCT00064584   111  20.051067  imi_mug_ct4   \n",
       "15700        50  Q0  NCT02440568   112  19.858310  imi_mug_ct4   \n",
       "15701        50  Q0  NCT01202877   113  19.011343  imi_mug_ct4   \n",
       "15702        50  Q0  NCT02141477   114  18.775341  imi_mug_ct4   \n",
       "15703        50  Q0  NCT00887068   115  18.490473  imi_mug_ct4   \n",
       "15704        50  Q0  NCT01830361   116  18.398415  imi_mug_ct4   \n",
       "15705        50  Q0  NCT01272245   117  18.079590  imi_mug_ct4   \n",
       "15706        50  Q0  NCT02323113   118  17.856297  imi_mug_ct4   \n",
       "15707        50  Q0  NCT00972101   119  17.804995  imi_mug_ct4   \n",
       "15708        50  Q0  NCT01028716   120  17.304775  imi_mug_ct4   \n",
       "15709        50  Q0  NCT01296178   121  16.886444  imi_mug_ct4   \n",
       "15710        50  Q0  NCT00498316   122  16.815830  imi_mug_ct4   \n",
       "15711        50  Q0  NCT01518153   123  16.327097  imi_mug_ct4   \n",
       "15712        50  Q0  NCT00580450   124  14.763527  imi_mug_ct4   \n",
       "15713        50  Q0  NCT01983761   125  13.991444  imi_mug_ct4   \n",
       "15714        50  Q0  NCT01875237   126  13.624058  imi_mug_ct4   \n",
       "15715        50  Q0  NCT00679536   127  10.838383  imi_mug_ct4   \n",
       "15716        50  Q0  NCT02420873   128   9.855232  imi_mug_ct4   \n",
       "15717        50  Q0  NCT02747537   129   8.351846  imi_mug_ct4   \n",
       "15718        50  Q0  NCT01892371   130   7.041186  imi_mug_ct4   \n",
       "15719        50  Q0  NCT00411151   131   6.901406  imi_mug_ct4   \n",
       "\n",
       "                                                   TITLE  \n",
       "0      Dabrafenib Plus Trametinib vs Vemurafenib Alon...  \n",
       "1      A Study of the Effect of Food on the Pharmacok...  \n",
       "2      A Study Comparing Trametinib and Dabrafenib Co...  \n",
       "3      A Pharmacokinetic\\/Pharmacodynamic Study of RO...  \n",
       "4      A Pharmacokinetic and Metabolism Study of 14C-...  \n",
       "5      A Phase I Study of Oral LGX818 in Adult Patien...  \n",
       "6      A Study of Vemurafenib in Previously Treated P...  \n",
       "7      A Study of Vemurafenib (RO5185426) in Comparis...  \n",
       "8      Japan PhI\\/II of GSK2118436 and GSK1120212 Com...  \n",
       "9      Study Comparing Combination of LGX818 Plus MEK...  \n",
       "10     Phase 1 Safety and Tolerability of MEDI4736 in...  \n",
       "11     GSK1120212 vs Chemotherapy in Advanced or Meta...  \n",
       "12     LY3022855 With BRAF\\/MEK Inhibition in Patient...  \n",
       "13     Access Study of Trametinib for Subjects With A...  \n",
       "14     A Phase Ib\\/II Study of LGX818 in Combination ...  \n",
       "15     A Study of Fotemustine(FTM) Vs FTM and Ipilimu...  \n",
       "16     A Phase I Trial of Vemurafenib and Hydroxychlo...  \n",
       "17     Vaccine Therapy in Treating Patients With Adva...  \n",
       "18     Phase I-II Study With Tumor Molecular Pharmaco...  \n",
       "19     Pharmacokinetics of Repeat Oral Doses of Dabra...  \n",
       "20     Trial of Vemurafenib and Cobimetinib in Patien...  \n",
       "21     Dabrafenib\\/Trametinib, BRAF or BRAF AND MEK P...  \n",
       "22     A Study of the BRAF Inhibitor Dabrafenib in Co...  \n",
       "23     Safety Study of PLX4032 in Patients With Solid...  \n",
       "24     A Study of RO5185426 in Patients With Metastat...  \n",
       "25     Trial of MEK Inhibitor and PI3K\\/mTOR Inhibito...  \n",
       "26     A Study of GSK2118436 in BRAF Mutant Metastati...  \n",
       "27     Phase 2 Study of Neoadjuvant Vemurafenib in Me...  \n",
       "28           Radiotherapy & Combi in Metastatic Melanoma  \n",
       "29     Phase II Biomarker Study Comparing the Combina...  \n",
       "...                                                  ...  \n",
       "15690  Personalized Natural Killer (NK) Cell Therapy ...  \n",
       "15691  A Study of E6201 for the Treatment of Advanced...  \n",
       "15692  Natural Killer (NK) Cells in Cord Blood Transp...  \n",
       "15693  Reduced Intensity, Partially HLA Mismatched BM...  \n",
       "15694  Shorter Course Tacrolimus After Nonmyeloablati...  \n",
       "15695  Maintenance Low Dose 5'-Azacitidine Post T Cel...  \n",
       "15696  Single vs Double Umbilical Cord Blood Transpla...  \n",
       "15697  Standard of Care +\\/- Midostaurin to Prevent R...  \n",
       "15698  Nonmyeloablative Hematopoietic Cell Transplant...  \n",
       "15699  Safety and Tolerance Study of Oral Doses of CT...  \n",
       "15700  AML-02: Omacetaxine With Standard-of-Care Indu...  \n",
       "15701                           PKC412 and 5-Azacytidine  \n",
       "15702  Omacetaxine and Decitabine in Acute Myelogenou...  \n",
       "15703  Controlled Study of Post-transplant Azacitidin...  \n",
       "15704  Trial to Assess the Efficacy of Midostaurin (P...  \n",
       "15705  Omacetaxine and Low Dose Cytarabine in Older P...  \n",
       "15706  Safety, Tolerability, and Efficacy of TAK-659 ...  \n",
       "15707            Infusion of Expanded Cord Blood T Cells  \n",
       "15708  Donor Peripheral Blood Stem Cell Transplant in...  \n",
       "15709  PETHEMA-LMA10: Treatment of Acute Myeloblastic...  \n",
       "15710     Cord Blood Expansion on Mesenchymal Stem Cells  \n",
       "15711  Planned Donor Lymphocyte Infusion (DLI) After ...  \n",
       "15712  Thymosin Alfa 1 in Recipients of Allogeneic He...  \n",
       "15713  Study of ASC-101 in Patients With Hematologic ...  \n",
       "15714  Donor Lymphocyte Infusion (DLI) of T-cells Gen...  \n",
       "15715  Allogeneic Transplantation for Pediatric Leuke...  \n",
       "15716  An Open-label Phase II Study of Lorvotuzumab M...  \n",
       "15717  Treating Relapsed\\/Recurrent\\/Refractory Pedia...  \n",
       "15718            AC220 With 5-Aza or Low Dose Cytarabine  \n",
       "15719  Efficacy and Safety of Sunitinib in Metastatic...  \n",
       "\n",
       "[15720 rows x 7 columns]"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "run, run_params = running.run(topics_2018, 'TRIALS', run_params)\n",
    "run"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "utils.to_trec_run_file(run, run_params)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## SUBMITTED RUN 5\n",
    "\n",
    "Baseline query with bi and tri-gram search, weighed, plus grid-search optimized parameters. Evaluation: 1."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Evaluate on 2017 topics and qrels first."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RUN: imi_mug_ct5 TOPICS: 30\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "{'recall_1000': 0.4426, 'ndcg': 0.3924, 'Rprec': 0.239, 'P_10': 0.3241}"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "run_params = {\n",
    "    'run_id':'imi_mug_ct5',\n",
    "    'query_template':'submitted/imi_mug_ct5.json'\n",
    "}\n",
    "\n",
    "run, params = running.run(topics_2017, 'TRIALS', run_params)\n",
    "results, aggregated = evaluation.evaluate(qrels_2017, run)\n",
    "\n",
    "aggregated"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Run on 2018 topics and export to file for submission"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RUN: imi_mug_ct5 TOPICS: 50\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>TOPIC_NO</th>\n",
       "      <th>Q0</th>\n",
       "      <th>ID</th>\n",
       "      <th>RANK</th>\n",
       "      <th>SCORE</th>\n",
       "      <th>RUN_NAME</th>\n",
       "      <th>TITLE</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01928940</td>\n",
       "      <td>1</td>\n",
       "      <td>55.552708</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Japan PhI\\/II of GSK2118436 and GSK1120212 Com...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT03101254</td>\n",
       "      <td>2</td>\n",
       "      <td>52.372395</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>LY3022855 With BRAF\\/MEK Inhibition in Patient...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01897116</td>\n",
       "      <td>3</td>\n",
       "      <td>51.414783</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>A Phase I Trial of Vemurafenib and Hydroxychlo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02427893</td>\n",
       "      <td>4</td>\n",
       "      <td>48.623820</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Trial of Vemurafenib and Cobimetinib in Patien...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02416232</td>\n",
       "      <td>5</td>\n",
       "      <td>47.371696</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Access Study of Trametinib for Subjects With A...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01597908</td>\n",
       "      <td>6</td>\n",
       "      <td>46.444664</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Dabrafenib Plus Trametinib vs Vemurafenib Alon...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01584648</td>\n",
       "      <td>7</td>\n",
       "      <td>44.805202</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>A Study Comparing Trametinib and Dabrafenib Co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01264380</td>\n",
       "      <td>8</td>\n",
       "      <td>42.995018</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>A Study of the Effect of Food on the Pharmacok...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01682083</td>\n",
       "      <td>9</td>\n",
       "      <td>41.778420</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>A Study of the BRAF Inhibitor Dabrafenib in Co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01436656</td>\n",
       "      <td>10</td>\n",
       "      <td>39.999750</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>A Phase I Study of Oral LGX818 in Adult Patien...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01266967</td>\n",
       "      <td>11</td>\n",
       "      <td>39.986570</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>A Study of GSK2118436 in BRAF Mutant Metastati...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01245062</td>\n",
       "      <td>12</td>\n",
       "      <td>39.969494</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>GSK1120212 vs Chemotherapy in Advanced or Meta...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01107418</td>\n",
       "      <td>13</td>\n",
       "      <td>39.188908</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>A Pharmacokinetic\\/Pharmacodynamic Study of RO...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01978236</td>\n",
       "      <td>14</td>\n",
       "      <td>39.113327</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Dabrafenib\\/Trametinib, BRAF or BRAF AND MEK P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01909453</td>\n",
       "      <td>15</td>\n",
       "      <td>38.268850</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Study Comparing Combination of LGX818 Plus MEK...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00949702</td>\n",
       "      <td>16</td>\n",
       "      <td>38.208683</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>A Study of Vemurafenib in Previously Treated P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01164891</td>\n",
       "      <td>17</td>\n",
       "      <td>38.160786</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>A Pharmacokinetic and Metabolism Study of 14C-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01586195</td>\n",
       "      <td>18</td>\n",
       "      <td>37.346030</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Study Of Zelboraf (Vemurafenib) in Patients Wi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02027961</td>\n",
       "      <td>19</td>\n",
       "      <td>37.018950</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Phase 1 Safety and Tolerability of MEDI4736 in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01006980</td>\n",
       "      <td>20</td>\n",
       "      <td>36.923980</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>A Study of Vemurafenib (RO5185426) in Comparis...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01400451</td>\n",
       "      <td>21</td>\n",
       "      <td>35.274048</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Ph I Ipilimumab Vemurafenib Combo in Patients ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02460068</td>\n",
       "      <td>22</td>\n",
       "      <td>34.485817</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>A Study of Fotemustine(FTM) Vs FTM and Ipilimu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00405587</td>\n",
       "      <td>23</td>\n",
       "      <td>34.037174</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Safety Study of PLX4032 in Patients With Solid...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01878396</td>\n",
       "      <td>24</td>\n",
       "      <td>32.723860</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Circulating Melanoma Cells in Metastatic Patie...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01744171</td>\n",
       "      <td>25</td>\n",
       "      <td>32.670143</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Vaccine Therapy in Treating Patients With Adva...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01543698</td>\n",
       "      <td>26</td>\n",
       "      <td>32.159830</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>A Phase Ib\\/II Study of LGX818 in Combination ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT03088176</td>\n",
       "      <td>27</td>\n",
       "      <td>31.982836</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Combining Talimogene Laherparepvec With BRAF a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02202200</td>\n",
       "      <td>28</td>\n",
       "      <td>31.858398</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Phase I-II Study With Tumor Molecular Pharmaco...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01943422</td>\n",
       "      <td>29</td>\n",
       "      <td>31.196007</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Safety and Efficacy Study of Vemurafenib and H...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>1</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02392871</td>\n",
       "      <td>30</td>\n",
       "      <td>31.106207</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Radiotherapy &amp; Combi in Metastatic Melanoma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15690</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00597519</td>\n",
       "      <td>102</td>\n",
       "      <td>14.748605</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>A Myeloablative Conditioning Regimen and Total...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15691</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02399917</td>\n",
       "      <td>103</td>\n",
       "      <td>14.736656</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>An Open-label Study of Lirilumab (BMS-986015) ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15692</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02141477</td>\n",
       "      <td>104</td>\n",
       "      <td>14.694950</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Omacetaxine and Decitabine in Acute Myelogenou...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15693</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01619761</td>\n",
       "      <td>105</td>\n",
       "      <td>14.591252</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Natural Killer (NK) Cells in Cord Blood Transp...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15694</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02752035</td>\n",
       "      <td>106</td>\n",
       "      <td>14.330658</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>A Study of ASP2215 (Gilteritinib), Combination...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15695</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00887068</td>\n",
       "      <td>107</td>\n",
       "      <td>13.965541</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Controlled Study of Post-transplant Azacitidin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15696</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT03016806</td>\n",
       "      <td>108</td>\n",
       "      <td>13.896956</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Combined Cord Blood Transplant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15697</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01300611</td>\n",
       "      <td>109</td>\n",
       "      <td>13.876300</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>TXA127 in Enhancement of Engraftment in Adult ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15698</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01272245</td>\n",
       "      <td>110</td>\n",
       "      <td>13.760099</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Omacetaxine and Low Dose Cytarabine in Older P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15699</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02727803</td>\n",
       "      <td>111</td>\n",
       "      <td>13.632661</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Personalized Natural Killer (NK) Cell Therapy ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15700</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01883362</td>\n",
       "      <td>112</td>\n",
       "      <td>13.189145</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Standard of Care +\\/- Midostaurin to Prevent R...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15701</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01203722</td>\n",
       "      <td>113</td>\n",
       "      <td>13.118571</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Reduced Intensity, Partially HLA Mismatched BM...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15702</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02323113</td>\n",
       "      <td>114</td>\n",
       "      <td>12.988543</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Safety, Tolerability, and Efficacy of TAK-659 ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15703</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01995578</td>\n",
       "      <td>115</td>\n",
       "      <td>12.756809</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Maintenance Low Dose 5'-Azacitidine Post T Cel...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15704</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01342289</td>\n",
       "      <td>116</td>\n",
       "      <td>12.353203</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Shorter Course Tacrolimus After Nonmyeloablati...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15705</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01830361</td>\n",
       "      <td>117</td>\n",
       "      <td>12.322121</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Trial to Assess the Efficacy of Midostaurin (P...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15706</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00412360</td>\n",
       "      <td>118</td>\n",
       "      <td>12.203186</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Single vs Double Umbilical Cord Blood Transpla...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15707</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02167958</td>\n",
       "      <td>119</td>\n",
       "      <td>10.630949</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Nonmyeloablative Hematopoietic Cell Transplant...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15708</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00972101</td>\n",
       "      <td>120</td>\n",
       "      <td>9.946753</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Infusion of Expanded Cord Blood T Cells</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15709</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01028716</td>\n",
       "      <td>121</td>\n",
       "      <td>9.696621</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Donor Peripheral Blood Stem Cell Transplant in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15710</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00498316</td>\n",
       "      <td>122</td>\n",
       "      <td>9.452005</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Cord Blood Expansion on Mesenchymal Stem Cells</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15711</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01518153</td>\n",
       "      <td>123</td>\n",
       "      <td>9.356202</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Planned Donor Lymphocyte Infusion (DLI) After ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15712</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01983761</td>\n",
       "      <td>124</td>\n",
       "      <td>8.474945</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Study of ASC-101 in Patients With Hematologic ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15713</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01875237</td>\n",
       "      <td>125</td>\n",
       "      <td>8.014325</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Donor Lymphocyte Infusion (DLI) of T-cells Gen...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15714</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00580450</td>\n",
       "      <td>126</td>\n",
       "      <td>7.926899</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Thymosin Alfa 1 in Recipients of Allogeneic He...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15715</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02747537</td>\n",
       "      <td>127</td>\n",
       "      <td>7.222199</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Treating Relapsed\\/Recurrent\\/Refractory Pedia...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15716</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00679536</td>\n",
       "      <td>128</td>\n",
       "      <td>6.463827</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Allogeneic Transplantation for Pediatric Leuke...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15717</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT00411151</td>\n",
       "      <td>129</td>\n",
       "      <td>5.487846</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>Efficacy and Safety of Sunitinib in Metastatic...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15718</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT02420873</td>\n",
       "      <td>130</td>\n",
       "      <td>5.471872</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>An Open-label Phase II Study of Lorvotuzumab M...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15719</th>\n",
       "      <td>50</td>\n",
       "      <td>Q0</td>\n",
       "      <td>NCT01892371</td>\n",
       "      <td>131</td>\n",
       "      <td>4.064826</td>\n",
       "      <td>imi_mug_ct5</td>\n",
       "      <td>AC220 With 5-Aza or Low Dose Cytarabine</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>15720 rows × 7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       TOPIC_NO  Q0           ID  RANK      SCORE     RUN_NAME  \\\n",
       "0             1  Q0  NCT01928940     1  55.552708  imi_mug_ct5   \n",
       "1             1  Q0  NCT03101254     2  52.372395  imi_mug_ct5   \n",
       "2             1  Q0  NCT01897116     3  51.414783  imi_mug_ct5   \n",
       "3             1  Q0  NCT02427893     4  48.623820  imi_mug_ct5   \n",
       "4             1  Q0  NCT02416232     5  47.371696  imi_mug_ct5   \n",
       "5             1  Q0  NCT01597908     6  46.444664  imi_mug_ct5   \n",
       "6             1  Q0  NCT01584648     7  44.805202  imi_mug_ct5   \n",
       "7             1  Q0  NCT01264380     8  42.995018  imi_mug_ct5   \n",
       "8             1  Q0  NCT01682083     9  41.778420  imi_mug_ct5   \n",
       "9             1  Q0  NCT01436656    10  39.999750  imi_mug_ct5   \n",
       "10            1  Q0  NCT01266967    11  39.986570  imi_mug_ct5   \n",
       "11            1  Q0  NCT01245062    12  39.969494  imi_mug_ct5   \n",
       "12            1  Q0  NCT01107418    13  39.188908  imi_mug_ct5   \n",
       "13            1  Q0  NCT01978236    14  39.113327  imi_mug_ct5   \n",
       "14            1  Q0  NCT01909453    15  38.268850  imi_mug_ct5   \n",
       "15            1  Q0  NCT00949702    16  38.208683  imi_mug_ct5   \n",
       "16            1  Q0  NCT01164891    17  38.160786  imi_mug_ct5   \n",
       "17            1  Q0  NCT01586195    18  37.346030  imi_mug_ct5   \n",
       "18            1  Q0  NCT02027961    19  37.018950  imi_mug_ct5   \n",
       "19            1  Q0  NCT01006980    20  36.923980  imi_mug_ct5   \n",
       "20            1  Q0  NCT01400451    21  35.274048  imi_mug_ct5   \n",
       "21            1  Q0  NCT02460068    22  34.485817  imi_mug_ct5   \n",
       "22            1  Q0  NCT00405587    23  34.037174  imi_mug_ct5   \n",
       "23            1  Q0  NCT01878396    24  32.723860  imi_mug_ct5   \n",
       "24            1  Q0  NCT01744171    25  32.670143  imi_mug_ct5   \n",
       "25            1  Q0  NCT01543698    26  32.159830  imi_mug_ct5   \n",
       "26            1  Q0  NCT03088176    27  31.982836  imi_mug_ct5   \n",
       "27            1  Q0  NCT02202200    28  31.858398  imi_mug_ct5   \n",
       "28            1  Q0  NCT01943422    29  31.196007  imi_mug_ct5   \n",
       "29            1  Q0  NCT02392871    30  31.106207  imi_mug_ct5   \n",
       "...         ...  ..          ...   ...        ...          ...   \n",
       "15690        50  Q0  NCT00597519   102  14.748605  imi_mug_ct5   \n",
       "15691        50  Q0  NCT02399917   103  14.736656  imi_mug_ct5   \n",
       "15692        50  Q0  NCT02141477   104  14.694950  imi_mug_ct5   \n",
       "15693        50  Q0  NCT01619761   105  14.591252  imi_mug_ct5   \n",
       "15694        50  Q0  NCT02752035   106  14.330658  imi_mug_ct5   \n",
       "15695        50  Q0  NCT00887068   107  13.965541  imi_mug_ct5   \n",
       "15696        50  Q0  NCT03016806   108  13.896956  imi_mug_ct5   \n",
       "15697        50  Q0  NCT01300611   109  13.876300  imi_mug_ct5   \n",
       "15698        50  Q0  NCT01272245   110  13.760099  imi_mug_ct5   \n",
       "15699        50  Q0  NCT02727803   111  13.632661  imi_mug_ct5   \n",
       "15700        50  Q0  NCT01883362   112  13.189145  imi_mug_ct5   \n",
       "15701        50  Q0  NCT01203722   113  13.118571  imi_mug_ct5   \n",
       "15702        50  Q0  NCT02323113   114  12.988543  imi_mug_ct5   \n",
       "15703        50  Q0  NCT01995578   115  12.756809  imi_mug_ct5   \n",
       "15704        50  Q0  NCT01342289   116  12.353203  imi_mug_ct5   \n",
       "15705        50  Q0  NCT01830361   117  12.322121  imi_mug_ct5   \n",
       "15706        50  Q0  NCT00412360   118  12.203186  imi_mug_ct5   \n",
       "15707        50  Q0  NCT02167958   119  10.630949  imi_mug_ct5   \n",
       "15708        50  Q0  NCT00972101   120   9.946753  imi_mug_ct5   \n",
       "15709        50  Q0  NCT01028716   121   9.696621  imi_mug_ct5   \n",
       "15710        50  Q0  NCT00498316   122   9.452005  imi_mug_ct5   \n",
       "15711        50  Q0  NCT01518153   123   9.356202  imi_mug_ct5   \n",
       "15712        50  Q0  NCT01983761   124   8.474945  imi_mug_ct5   \n",
       "15713        50  Q0  NCT01875237   125   8.014325  imi_mug_ct5   \n",
       "15714        50  Q0  NCT00580450   126   7.926899  imi_mug_ct5   \n",
       "15715        50  Q0  NCT02747537   127   7.222199  imi_mug_ct5   \n",
       "15716        50  Q0  NCT00679536   128   6.463827  imi_mug_ct5   \n",
       "15717        50  Q0  NCT00411151   129   5.487846  imi_mug_ct5   \n",
       "15718        50  Q0  NCT02420873   130   5.471872  imi_mug_ct5   \n",
       "15719        50  Q0  NCT01892371   131   4.064826  imi_mug_ct5   \n",
       "\n",
       "                                                   TITLE  \n",
       "0      Japan PhI\\/II of GSK2118436 and GSK1120212 Com...  \n",
       "1      LY3022855 With BRAF\\/MEK Inhibition in Patient...  \n",
       "2      A Phase I Trial of Vemurafenib and Hydroxychlo...  \n",
       "3      Trial of Vemurafenib and Cobimetinib in Patien...  \n",
       "4      Access Study of Trametinib for Subjects With A...  \n",
       "5      Dabrafenib Plus Trametinib vs Vemurafenib Alon...  \n",
       "6      A Study Comparing Trametinib and Dabrafenib Co...  \n",
       "7      A Study of the Effect of Food on the Pharmacok...  \n",
       "8      A Study of the BRAF Inhibitor Dabrafenib in Co...  \n",
       "9      A Phase I Study of Oral LGX818 in Adult Patien...  \n",
       "10     A Study of GSK2118436 in BRAF Mutant Metastati...  \n",
       "11     GSK1120212 vs Chemotherapy in Advanced or Meta...  \n",
       "12     A Pharmacokinetic\\/Pharmacodynamic Study of RO...  \n",
       "13     Dabrafenib\\/Trametinib, BRAF or BRAF AND MEK P...  \n",
       "14     Study Comparing Combination of LGX818 Plus MEK...  \n",
       "15     A Study of Vemurafenib in Previously Treated P...  \n",
       "16     A Pharmacokinetic and Metabolism Study of 14C-...  \n",
       "17     Study Of Zelboraf (Vemurafenib) in Patients Wi...  \n",
       "18     Phase 1 Safety and Tolerability of MEDI4736 in...  \n",
       "19     A Study of Vemurafenib (RO5185426) in Comparis...  \n",
       "20     Ph I Ipilimumab Vemurafenib Combo in Patients ...  \n",
       "21     A Study of Fotemustine(FTM) Vs FTM and Ipilimu...  \n",
       "22     Safety Study of PLX4032 in Patients With Solid...  \n",
       "23     Circulating Melanoma Cells in Metastatic Patie...  \n",
       "24     Vaccine Therapy in Treating Patients With Adva...  \n",
       "25     A Phase Ib\\/II Study of LGX818 in Combination ...  \n",
       "26     Combining Talimogene Laherparepvec With BRAF a...  \n",
       "27     Phase I-II Study With Tumor Molecular Pharmaco...  \n",
       "28     Safety and Efficacy Study of Vemurafenib and H...  \n",
       "29           Radiotherapy & Combi in Metastatic Melanoma  \n",
       "...                                                  ...  \n",
       "15690  A Myeloablative Conditioning Regimen and Total...  \n",
       "15691  An Open-label Study of Lirilumab (BMS-986015) ...  \n",
       "15692  Omacetaxine and Decitabine in Acute Myelogenou...  \n",
       "15693  Natural Killer (NK) Cells in Cord Blood Transp...  \n",
       "15694  A Study of ASP2215 (Gilteritinib), Combination...  \n",
       "15695  Controlled Study of Post-transplant Azacitidin...  \n",
       "15696                     Combined Cord Blood Transplant  \n",
       "15697  TXA127 in Enhancement of Engraftment in Adult ...  \n",
       "15698  Omacetaxine and Low Dose Cytarabine in Older P...  \n",
       "15699  Personalized Natural Killer (NK) Cell Therapy ...  \n",
       "15700  Standard of Care +\\/- Midostaurin to Prevent R...  \n",
       "15701  Reduced Intensity, Partially HLA Mismatched BM...  \n",
       "15702  Safety, Tolerability, and Efficacy of TAK-659 ...  \n",
       "15703  Maintenance Low Dose 5'-Azacitidine Post T Cel...  \n",
       "15704  Shorter Course Tacrolimus After Nonmyeloablati...  \n",
       "15705  Trial to Assess the Efficacy of Midostaurin (P...  \n",
       "15706  Single vs Double Umbilical Cord Blood Transpla...  \n",
       "15707  Nonmyeloablative Hematopoietic Cell Transplant...  \n",
       "15708            Infusion of Expanded Cord Blood T Cells  \n",
       "15709  Donor Peripheral Blood Stem Cell Transplant in...  \n",
       "15710     Cord Blood Expansion on Mesenchymal Stem Cells  \n",
       "15711  Planned Donor Lymphocyte Infusion (DLI) After ...  \n",
       "15712  Study of ASC-101 in Patients With Hematologic ...  \n",
       "15713  Donor Lymphocyte Infusion (DLI) of T-cells Gen...  \n",
       "15714  Thymosin Alfa 1 in Recipients of Allogeneic He...  \n",
       "15715  Treating Relapsed\\/Recurrent\\/Refractory Pedia...  \n",
       "15716  Allogeneic Transplantation for Pediatric Leuke...  \n",
       "15717  Efficacy and Safety of Sunitinib in Metastatic...  \n",
       "15718  An Open-label Phase II Study of Lorvotuzumab M...  \n",
       "15719            AC220 With 5-Aza or Low Dose Cytarabine  \n",
       "\n",
       "[15720 rows x 7 columns]"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "run, run_params = running.run(topics_2018, 'TRIALS', run_params)\n",
    "run"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "utils.to_trec_run_file(run, run_params)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.1"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
